RxNorm Semantic Concepts Index - 136
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "136".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 136 | Abrin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 136 | Abrin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360000 | atropine sulfate 2.86 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360001 | meperidine hydrochloride 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360002 | hydromorphone hydrochloride 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360002 | hydromorphone hydrochloride 1 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360004 | atropine sulfate 0.833 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360005 | alprostadil 0.04 MG/ML Prefilled Syringe [Caverject] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360006 | vitamin B12 1 MG/ML Prefilled Syringe [Rubramin PC] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360007 | tinzaparin sodium 10000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360008 | peginterferon alfa-2a 0.27 MG/ML Prefilled Syringe [Pegasys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360009 | midazolam 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360011 | phenylephrine hydrochloride 0.1 MG/mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360011 | phenylephrine hydrochloride 0.1 MG/mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360013 | paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360014 | EPO 20000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360014 | EPO 20000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360014 | EPO 20000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360015 | beclomethasone dipropionate 0.042 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360016 | albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Ventolin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360016 | albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Ventolin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360019 | ENX sodium 100 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360019 | ENX sodium 100 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360021 | selegiline 0.375 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360022 | cloNIDine 0.00417 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360022 | cloNIDine 0.00417 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360023 | estradiol 0.00208 MG/HR / norethindrone acetate 0.00583 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360024 | beclomethasone dipropionate 0.084 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360025 | ipratropium bromide 0.018 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360029 | tinzaparin sodium 20000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360030 | sodium hyaluronate 1 % prefilled syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360030 | sodium hyaluronate 1 % prefilled syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360032 | midazolam 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360033 | interferon alfa-2a 12000000 UNT/ML Prefilled Syringe [Roferon-A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360035 | hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe [Recombivax] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360036 | insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector [Humalog Mix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360036 | insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector [Humalog Mix] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360037 | interferon alfa-2b 3000000 UNT/ACTUAT Prefilled Syringe [Intron A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360038 | diphenhydramine hydrochloride 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360038 | diphenhydramine hydrochloride 50 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360039 | atropine sulfate 0.714 MG/ML Auto-Injector [Atropen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360039 | atropine sulfate 0.714 MG/ML Auto-Injector [Atropen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360041 | testosterone 0.208 MG/HR Transdermal System [Androderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360041 | testosterone 0.208 MG/HR Transdermal System [Androderm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360043 | testosterone 0.25 MG/HR Transdermal System [Testoderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360043 | testosterone 0.25 MG/HR Transdermal System [Testoderm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360044 | cloNIDine 0.0125 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360044 | cloNIDine 0.0125 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360046 | fluticasone propionate 0.25 MG/ACTUAT Dry Powder Inhaler [Flovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360047 | fluticasone propionate 250 MCG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360047 | fluticasone propionate 250 MCG/ACTUAT Dry Powder Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360047 | fluticasone propionate 250 MCG/ACTUAT Dry Powder Inhaler | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360047 | fluticasone propionate 250 MCG/ACTUAT Dry Powder Inhaler | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360048 | MS 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360048 | MS 2 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360049 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360050 | leuprolide acetate 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360051 | fulvestrant 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360052 | sodium hyaluronate 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360053 | peginterferon alfa-2b 0.24 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360054 | etomidate 2 MG/ML Prefilled Syringe [Amidate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360055 | lanreotide 240 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360056 | penicillin G procaine 600000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360057 | hepatitis B surface antigen vaccine 0.005 MG/ML Prefilled Syringe [Recombivax] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360058 | insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360059 | lidocaine hydrochloride 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360060 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360061 | hylan G-F 20 4.8 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360062 | nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360062 | nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360062 | nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360062 | nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360063 | formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.2 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360064 | fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [Advair] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360064 | fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [Advair] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360064 | fluticasone propionate 0.23 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [Advair] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360067 | fulvestrant 50 MG/ML Prefilled Syringe [Faslodex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360068 | hypromellose 18 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360069 | estradiol 0.00312 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360071 | fentanyl 0.025 MG/HR Transdermal System [Duragesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360071 | fentanyl 0.025 MG/HR Transdermal System [Duragesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360071 | fentanyl 0.025 MG/HR Transdermal System [Duragesic] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360072 | nicotine 0.625 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360073 | fluticasone propionate 220 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360073 | fluticasone propionate 220 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360074 | beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360074 | beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360075 | EPINEPHrine 0.22 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360075 | EPINEPHrine 0.22 MG/ACTUAT Metered Dose Inhaler | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360078 | somatropin 2.4 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360078 | somatropin 2.4 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360079 | tetanus immune globulin, human 250 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360081 | certolizumab pegol 200 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360082 | calcium chloride 0.68 MEQ/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360084 | somatropin 12 MG/ML Cartridge [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360084 | somatropin 12 MG/ML Cartridge [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360085 | peginesatide 2 MG/ML Prefilled Syringe [Omontys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360088 | hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360092 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2011-2012 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360093 | codeine phosphate 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360094 | hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360094 | hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360095 | interferon alfa-2a 6000000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360096 | pramlintide acetate 1 MG/ML Pen Injector [Symlin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360096 | pramlintide acetate 1 MG/ML Pen Injector [Symlin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360097 | adalimumab 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360098 | hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360099 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360100 | estradiol 0.00313 MG/HR Transdermal System [Vivelle] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360100 | estradiol 0.00313 MG/HR Transdermal System [Vivelle] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360101 | Granisetron 129.167 microgram/hour prolonged-release transdermal patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360101 | Granisetron 129.167 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360101 | Granisetron 129.167 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360104 | LORazepam 2 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360104 | LORazepam 2 MG/ML Cartridge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360105 | liraglutide 6 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360106 | MS 15 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360106 | MS 15 MG/ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360107 | rivastigmine 0.192 MG/HR Transdermal System [Exelon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360107 | rivastigmine 0.192 MG/HR Transdermal System [Exelon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360108 | nitroglycerin 0.2 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360108 | nitroglycerin 0.2 MG/HR Transdermal System [Nitrodisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360108 | nitroglycerin 0.2 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360108 | nitroglycerin 0.2 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360111 | rotigotine 0.333 MG/HR Transdermal System [Neupro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360111 | rotigotine 0.333 MG/HR Transdermal System [Neupro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360113 | methylphenidate 1.11 MG/HR Transdermal System [Daytrana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360113 | methylphenidate 1.11 MG/HR Transdermal System [Daytrana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360114 | methylphenidate 3.33 MG/HR Transdermal System [Daytrana] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360114 | methylphenidate 3.33 MG/HR Transdermal System [Daytrana] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360115 | nitroglycerin 0.6 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360115 | nitroglycerin 0.6 MG/HR Transdermal System [Minitran] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360115 | nitroglycerin 0.6 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360115 | nitroglycerin 0.6 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360119 | buprenorphine 0.0525 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360120 | cloNIDine 0.00833 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360120 | cloNIDine 0.00833 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360122 | rivastigmine 0.554 MG/HR Transdermal System [Exelon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360122 | rivastigmine 0.554 MG/HR Transdermal System [Exelon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360126 | ePHEDrine hydrochloride 3 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360126 | ePHEDrine hydrochloride 3 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360127 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360127 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360133 | baclofen 0.05 MG/ML Prefilled Syringe [Gablofen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360134 | atropine sulfate 2.86 MG/ML Auto-Injector [Atropen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360134 | atropine sulfate 2.86 MG/ML Auto-Injector [Atropen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360135 | naloxone hydrochloride 0.4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360136 | fibrinogen, human 106 MG/ML / thrombin, human 6.5 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360140 | thiopental 25 MG/ML Prefilled Syringe [Pentothal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360141 | somatropin 3.2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360142 | hepatitis B immune globulin 217 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360143 | ibandronic acid 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360144 | triamcinolone acetonide 40 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360145 | hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360146 | hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360147 | iopamidol 610 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360149 | diazepam 5 MG/ML Rectal Gel | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360149 | diazepam 5 MG/ML Rectal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360149 | diazepam 5 MG/ML Rectal Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360149 | diazepam 5 MG/ML Rectal Gel | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360151 | peginesatide 10 MG/ML Prefilled Syringe [Omontys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360152 | peginesatide 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360154 | estradiol 0.00417 MG/HR Transdermal System [Alora] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360154 | estradiol 0.00417 MG/HR Transdermal System [Alora] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360155 | nitroglycerin 0.8 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360155 | nitroglycerin 0.8 MG/HR Transdermal System [Nitro-Dur] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360155 | nitroglycerin 0.8 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360155 | nitroglycerin 0.8 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360156 | nicotine 0.875 MG/HR Transdermal System [Habitrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360156 | nicotine 0.875 MG/HR Transdermal System [Habitrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360157 | insulin human, rDNA origin 3 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360159 | cromolyn sodium 0.8 MG/ACTUAT Metered Dose Inhaler [Intal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360162 | EPO 10000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360162 | EPO 10000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360162 | EPO 10000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360163 | pegfilgrastim 10 MG/ML Prefilled Syringe [Neulasta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360164 | thiopental 25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360166 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Afluria 2011-2012 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360167 | leuprolide acetate 11.25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360168 | leuprolide acetate 11.25 MG/ML Prefilled Syringe [Lupron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360169 | sodium hyaluronate 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360170 | penicillin G benzathine 450000 UNT/ML / penicillin G procaine 150000 UNT/ML Prefilled Syringe [Bicillin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360171 | acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360172 | insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360173 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2010-2011 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360174 | estradiol 0.1 MG/Day Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360174 | estradiol 0.1 MG/Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360174 | estradiol 0.1 MG/Day Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360174 | estradiol 0.1 MG/Day Transdermal System | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360174 | estradiol 0.1 MG/Day Transdermal System | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360175 | nitroglycerin 0.2 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360175 | nitroglycerin 0.2 MG/HR Transdermal System [Deponit] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360175 | nitroglycerin 0.2 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360175 | nitroglycerin 0.2 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360178 | budesonide 0.09 MG/ACTUAT Dry Powder Inhaler [Pulmicort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360178 | budesonide 0.09 MG/ACTUAT Dry Powder Inhaler [Pulmicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360179 | leuprolide acetate 3.75 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360180 | MS 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360180 | MS 10 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360181 | methohexital sodium 10 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360181 | methohexital sodium 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360182 | fondaparinux sodium 5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360183 | ketorolac tromethamine 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360184 | pramlintide acetate 1 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360185 | leuprolide acetate 15 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360186 | alprostadil 0.04 MG/ML Cartridge [Edex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360186 | alprostadil 0.04 MG/ML Cartridge [Edex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360187 | bupivacaine hydrochloride 2.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360187 | bupivacaine hydrochloride 2.5 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360188 | meperidine hydrochloride 100 MG/ML Cartridge [Demerol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360188 | meperidine hydrochloride 100 MG/ML Cartridge [Demerol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360189 | somatropin 7.2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360190 | somatropin 2.5 MG/ML Pen Injector [Nutropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360190 | somatropin 2.5 MG/ML Pen Injector [Nutropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360192 | estradiol 0.00208 MG/HR Transdermal System [Esclim] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360192 | estradiol 0.00208 MG/HR Transdermal System [Esclim] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360193 | estradiol 0.00188 MG/HR / levonorgestrel 0.000625 MG/HR Transdermal System [Climara Pro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360194 | fentaNYL 0.075 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360194 | fentaNYL 0.075 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360194 | fentaNYL 0.075 MG/HR Transdermal System | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360194 | fentaNYL 0.075 MG/HR Transdermal System | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360195 | estradiol 0.0025 MG/HR Transdermal System [Climara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360195 | estradiol 0.0025 MG/HR Transdermal System [Climara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360196 | estradiol 0.00208 MG/HR Transdermal System [Alora] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360196 | estradiol 0.00208 MG/HR Transdermal System [Alora] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360197 | rotigotine 0.25 MG/HR Transdermal System [Neupro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360197 | rotigotine 0.25 MG/HR Transdermal System [Neupro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360199 | nicotine 0.917 MG/HR Transdermal System [ProStep] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360199 | nicotine 0.917 MG/HR Transdermal System [ProStep] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360200 | fluticasone propionate 50 MCG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360200 | fluticasone propionate 50 MCG/ACTUAT Dry Powder Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360200 | fluticasone propionate 50 MCG/ACTUAT Dry Powder Inhaler | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360200 | fluticasone propionate 50 MCG/ACTUAT Dry Powder Inhaler | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360201 | albuterol 90 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360201 | albuterol 90 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360202 | pirbuterol acetate 200 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360202 | pirbuterol acetate 200 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360206 | leuprolide acetate 120 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360207 | epinephrine 1 MG/ML Auto-Injector [Adrenaclick] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360207 | epinephrine 1 MG/ML Auto-Injector [Adrenaclick] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360207 | epinephrine 1 MG/ML Auto-Injector [Adrenaclick] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360208 | cephapirin 30 MG/ML Prefilled Syringe [Tomorrow] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360209 | somatropin 5.6 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360209 | somatropin 5.6 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360212 | sodium bicarbonate 4.2 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360212 | sodium bicarbonate 4.2 % Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360212 | sodium bicarbonate 4.2 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360213 | isoproterenol hydrochloride 0.02 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360215 | rotigotine 0.0417 MG/HR Transdermal System [Neupro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360215 | rotigotine 0.0417 MG/HR Transdermal System [Neupro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360216 | fluticasone propionate 0.1 MG/ACTUAT Dry Powder Inhaler [Flovent] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360216 | fluticasone propionate 0.1 MG/ACTUAT Dry Powder Inhaler [Flovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360217 | budesonide 0.09 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360219 | chondroitin sulfates 40 MG/ML / sodium hyaluronate 17 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360220 | enoxaparin sodium 150 MG/ML Prefilled Syringe [Lovenox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360220 | enoxaparin sodium 150 MG/ML Prefilled Syringe [Lovenox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360221 | somatropin 10 MG/ML Pen Injector [Norditropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360221 | somatropin 10 MG/ML Pen Injector [Norditropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360223 | sodium hyaluronate 14 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360224 | peginterferon alfa-2b 0.1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360225 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360226 | insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Prefilled Syringe [Novolin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360226 | insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Prefilled Syringe [Novolin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360228 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360229 | somatropin 12 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360231 | ondansetron 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360232 | rotigotine 0.25 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360233 | testosterone 0.0833 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360234 | nicotine 0.292 MG/HR Transdermal System [Habitrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360234 | nicotine 0.292 MG/HR Transdermal System [Habitrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360235 | formoterol fumarate 0.005 MG/ACTUAT / mometasone furoate 0.1 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360243 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2012-2013 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360244 | leuprolide acetate 7.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360245 | meperidine hydrochloride 25 MG/ML Cartridge [Demerol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360245 | meperidine hydrochloride 25 MG/ML Cartridge [Demerol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360247 | Estradiol 3.333 microgram/hour prolonged-release transdermal patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360247 | Estradiol 3.333 microgram/hour prolonged-release transdermal patch | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360247 | Estradiol 3.333 microgram/hour prolonged-release transdermal patch | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360249 | nicotine 0.583 MG/HR Transdermal System [Nicoderm C-Q] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360249 | nicotine 0.583 MG/HR Transdermal System [Nicoderm C-Q] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360251 | estradiol 0.000313 MG/HR Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360252 | triamcinolone acetonide 0.075 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360253 | ciclesonide 0.16 MG/ACTUAT Metered Dose Inhaler [Alvesco] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360257 | thiopental 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360259 | lidocaine hydrochloride 100 MG/ML Prefilled Syringe [LidoPen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360260 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360261 | nitroglycerin 0.1 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360261 | nitroglycerin 0.1 MG/HR Transdermal System [Minitran] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360261 | nitroglycerin 0.1 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360261 | nitroglycerin 0.1 MG/HR Transdermal System [Minitran] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360262 | nicotine 0.292 MG/HR Transdermal System [Nicoderm C-Q] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360262 | nicotine 0.292 MG/HR Transdermal System [Nicoderm C-Q] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360264 | estradiol 0.00104 MG/HR Transdermal System [Esclim] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360264 | estradiol 0.00104 MG/HR Transdermal System [Esclim] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360266 | estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal System [Combipatch] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360267 | rivastigmine 0.554 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360269 | ciclesonide 0.08 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360270 | Rho(D) immune globulin 1250 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360272 | somatropin 4.8 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360273 | bretylium 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360274 | interferon alfa-2a 0.0666 MG/ML Prefilled Syringe [Roferon-A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360275 | interferon beta-1a 0.088 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360276 | choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe [Ovidrel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360276 | choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe [Ovidrel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360277 | LORazepam 4 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360277 | LORazepam 4 MG/ML Cartridge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360278 | somatropin 3.33 MG/ML Pen Injector [Norditropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360278 | somatropin 3.33 MG/ML Pen Injector [Norditropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360279 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360281 | insulin detemir 100 UNT/ML Pen Injector [Levemir] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360281 | insulin detemir 100 UNT/ML Pen Injector [Levemir] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360283 | hydromorphone hydrochloride 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360283 | hydromorphone hydrochloride 0.5 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360285 | iopamidol 760 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360286 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360288 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360289 | methoxy polyethylene glycol-epoetin beta 0.25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360290 | hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360291 | pegfilgrastim 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360292 | albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Proventil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360293 | fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360293 | fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360294 | beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Inhaler [Qvar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360294 | beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Inhaler [Qvar] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360296 | sodium hyaluronate 23 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360297 | interferon alfa-2b 10000000 UNT/ACTUAT Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360298 | peginesatide 4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360299 | methylphenidate 1.67 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360300 | methylphenidate 3.33 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360304 | budesonide 80 MCG/ACTUAT / formoterol fumarate 4.5 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360304 | budesonide 80 MCG/ACTUAT / formoterol fumarate 4.5 MG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360307 | vitamin K1 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360308 | tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360309 | penicillin G benzathine 900000 UNT/ML / penicillin G procaine 300000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360311 | somatropin 6.4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360312 | acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360313 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe [Ixiaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360314 | phenylephrine hydrochloride 0.4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360316 | nicotine 0.875 MG/HR Transdermal System [Nicoderm C-Q] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360316 | nicotine 0.875 MG/HR Transdermal System [Nicoderm C-Q] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360317 | rotigotine 0.0833 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360320 | selegiline 0.375 MG/HR Transdermal System [Emsam] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360320 | selegiline 0.375 MG/HR Transdermal System [Emsam] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360321 | granisetron 0.129 MG/HR Transdermal System [Sancuso] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360321 | granisetron 0.129 MG/HR Transdermal System [Sancuso] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360322 | estradiol 0.000313 MG/HR Vaginal System [Estring] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360322 | estradiol 0.000313 MG/HR Vaginal System [Estring] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360323 | interferon alfa-2b 25000000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360324 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360325 | triamcinolone acetonide 80 MG/ML Prefilled Syringe [Trivaris] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360326 | sodium hyaluronate 12 MG/ML Prefilled Syringe [Amvisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360327 | lanreotide 300 MG/ML Prefilled Syringe [Somatuline] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360328 | somatropin 3.2 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360328 | somatropin 3.2 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360329 | NaHCO3 0.893 MEQ/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360329 | NaHCO3 0.893 MEQ/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360330 | phenylephrine hydrochloride 0.04 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360332 | fentanyl 0.012 MG/HR Transdermal System [Duragesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360332 | fentanyl 0.012 MG/HR Transdermal System [Duragesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360332 | fentanyl 0.012 MG/HR Transdermal System [Duragesic] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360333 | fluticasone propionate 110 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360333 | fluticasone propionate 110 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360334 | metaproterenol sulfate 0.65 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360336 | interferon alfa-2a 9000000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360337 | EPINEPHrine 0.5 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360337 | EPINEPHrine 0.5 MG/ML Auto-Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360339 | nitroglycerin 0.4 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360339 | nitroglycerin 0.4 MG/HR Transdermal System [Deponit] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360339 | nitroglycerin 0.4 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360339 | nitroglycerin 0.4 MG/HR Transdermal System [Deponit] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 136034 | ferrous lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1360340 | testosterone 0.0833 MG/HR Transdermal System [Androderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360340 | testosterone 0.0833 MG/HR Transdermal System [Androderm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360341 | fentaNYL 0.05 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360341 | fentaNYL 0.05 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360341 | fentaNYL 0.05 MG/HR Transdermal System | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360341 | fentaNYL 0.05 MG/HR Transdermal System | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360342 | estradiol 0.00104 MG/HR Transdermal System [Climara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360342 | estradiol 0.00104 MG/HR Transdermal System [Climara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360343 | nicotine 0.625 MG/HR Transdermal System [Nicotrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360343 | nicotine 0.625 MG/HR Transdermal System [Nicotrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360344 | estradiol 0.00208 MG/HR Vaginal System [Femring] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360344 | estradiol 0.00208 MG/HR Vaginal System [Femring] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360345 | epinephrine 0.22 MG/ACTUAT Metered Dose Inhaler [Primatene Mist Inhaler] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360348 | somatropin 8 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360348 | somatropin 8 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360350 | interferon alfa-2a 0.0666 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360351 | chondroitin sulfates 40 MG/ML / sodium hyaluronate 17 MG/ML Prefilled Syringe [DisCoVisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360352 | apomorphine 5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360353 | magnesium sulfate 4 MEQ/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360354 | L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe [Gardasil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360356 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Adacel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360357 | nitroglycerin 0.4 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360357 | nitroglycerin 0.4 MG/HR Transdermal System [Nitro-Dur] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360357 | nitroglycerin 0.4 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360357 | nitroglycerin 0.4 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360359 | zanamivir 5 MG/ACTUAT Dry Powder Inhaler [Relenza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360362 | darbepoetin alfa 0.06 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360363 | darbepoetin alfa 0.06 MG/ML Prefilled Syringe [Aranesp] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360364 | meperidine hydrochloride 75 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360366 | hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360367 | verapamil hydrochloride 2.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360368 | glatiramer acetate 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360369 | interferon beta-1a 0.06 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360370 | interferon alfa-2b 3000000 UNT/ACTUAT Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360371 | denosumab 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360372 | atropine sulfate 0.833 MG/ML Auto-Injector [Atropen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360372 | atropine sulfate 0.833 MG/ML Auto-Injector [Atropen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360373 | sodium hyaluronate 15 MG/ML Prefilled Syringe [Orthovisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360375 | estradiol 0.00156 MG/HR Transdermal System [Esclim] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360375 | estradiol 0.00156 MG/HR Transdermal System [Esclim] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360376 | rotigotine 0.167 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360377 | somatropin 2.4 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360378 | somatropin 0.8 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360378 | somatropin 0.8 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360379 | interferon alfa-2a 0.0222 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360380 | somatropin 5.6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360381 | SUMAtriptan 12 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360381 | SUMAtriptan 12 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360382 | interferon alfa-2a 18000000 UNT/ML Prefilled Syringe [Roferon-A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360383 | insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360383 | insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector [NovoLog Mix] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360384 | denosumab 60 MG/ML Prefilled Syringe [Prolia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360385 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360386 | nitroglycerin 0.6 MG/HR Transdermal System [Nitrek] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360386 | nitroglycerin 0.6 MG/HR Transdermal System [Nitrek] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360386 | nitroglycerin 0.6 MG/HR Transdermal System [Nitrek] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360386 | nitroglycerin 0.6 MG/HR Transdermal System [Nitrek] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360388 | TNG 0.4 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360388 | TNG 0.4 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360388 | TNG 0.4 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360389 | TNG 0.1 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360389 | TNG 0.1 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360389 | TNG 0.1 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360390 | estradiol 0.00104 MG/HR Transdermal System [Alora] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360390 | estradiol 0.00104 MG/HR Transdermal System [Alora] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360391 | TNG 0.2 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360391 | TNG 0.2 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360391 | TNG 0.2 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360392 | flunisolide 0.25 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360393 | albuterol 0.1 MG/ACTUAT / ipratropium bromide 0.02 MG/ACTUAT Inhalation Spray [Combivent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360394 | isoproterenol hydrochloride 0.131 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360398 | sodium hyaluronate 12 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360399 | interferon alfa-2a 6000000 UNT/ML Prefilled Syringe [Roferon-A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360400 | meperidine hydrochloride 100 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360401 | L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360402 | budesonide 180 MCG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360402 | budesonide 180 MCG/ACTUAT Dry Powder Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360403 | beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler [Qvar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360404 | levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360409 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360410 | methoxy polyethylene glycol-epoetin beta 0.667 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360413 | alprostadil 0.005 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360414 | peginterferon alfa-2b 0.3 MG/ML Prefilled Syringe [Pegintron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360416 | codeine phosphate 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360420 | NaHCO3 1 MEQ/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360420 | NaHCO3 1 MEQ/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360421 | ardeparin sodium 20000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360422 | testosterone 0.25 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360423 | rivastigmine 0.396 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360427 | epinephrine 0.5 MG/ML Auto-Injector [Epipen] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360427 | epinephrine 0.5 MG/ML Auto-Injector [Epipen] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360427 | epinephrine 0.5 MG/ML Auto-Injector [Epipen] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360428 | EPO 2000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360428 | EPO 2000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360428 | EPO 2000 UNT/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360429 | darbepoetin alfa 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360430 | etanercept 50 MG/ML Prefilled Syringe [Enbrel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360431 | poliovirus vaccine inactivated Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360431 | poliovirus vaccine inactivated Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360433 | diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Decavac] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360434 | interferon beta-1a 0.06 MG/ML Prefilled Syringe [Avonex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360435 | insulin, regular, human 100 UNT/ML Prefilled Syringe [Novolin R] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360435 | insulin, regular, human 100 UNT/ML Prefilled Syringe [Novolin R] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360436 | golimumab 100 MG/ML Prefilled Syringe [Simponi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360437 | interferon alfa-2b 5000000 UNT/ACTUAT Prefilled Syringe [Intron A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360438 | chondroitin sulfates 4 % / sodium hyaluronate 3 % Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360438 | chondroitin sulfates 4 % / sodium hyaluronate 3 % Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360439 | peginesatide 6 MG/ML Prefilled Syringe [Omontys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360440 | buprenorphine 0.01 MG/HR Transdermal System [BuTrans] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360440 | buprenorphine 0.01 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360441 | selegiline 0.25 MG/HR Transdermal System [Emsam] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360441 | selegiline 0.25 MG/HR Transdermal System [Emsam] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360442 | selegiline 0.5 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360443 | salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360443 | salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360443 | salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360443 | salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360444 | follitropin alfa 600 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360445 | tetanus immune globulin, human 250 UNT/ML Prefilled Syringe [Hypertet] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360445 | tetanus immune globulin, human 250 UNT/ML Prefilled Syringe [Hypertet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360447 | NaHCO3 75 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360447 | NaHCO3 75 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360448 | chondroitin sulfates 40 MG/ML / hyaluronate 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360449 | Rho(D) immune globulin, human 750 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360451 | alprostadil 0.02 MG/ML Cartridge [Edex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360451 | alprostadil 0.02 MG/ML Cartridge [Edex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360452 | atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector [Duodote] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360454 | exenatide 0.01 MG/ACTUAT Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360455 | sodium hyaluronate 12 MG/ML Prefilled Syringe [Shellgel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360457 | estradiol 0.00417 MG/HR Transdermal System [Minivelle] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360457 | estradiol 0.00417 MG/HR Transdermal System [Minivelle] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360458 | buprenorphine 0.02 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360459 | epinephrine 0.16 MG/ACTUAT Metered Dose Inhaler [Medihaler-Epi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360459 | epinephrine 0.16 MG/ACTUAT Metered Dose Inhaler [Medihaler-Epi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360462 | ganirelix acetate 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360463 | etomidate 2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360464 | interferon beta-1a 0.044 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360465 | dalteparin sodium 12500 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360467 | somatropin 5 MG/ML Cartridge [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360467 | somatropin 5 MG/ML Cartridge [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360468 | somatropin 1.6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360469 | methoxy polyethylene glycol-epoetin beta 0.5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360470 | peginterferon alfa-2b 0.24 MG/ML Prefilled Syringe [Pegintron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360471 | cephapirin 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360472 | somatropin 6.4 MG/ML Prefilled Syringe [Genotropin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360472 | somatropin 6.4 MG/ML Prefilled Syringe [Genotropin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360474 | ampicillin 6.25 MG/ML Prefilled Syringe [Hetacin-K] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360476 | nitroglycerin 0.3 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360476 | nitroglycerin 0.3 MG/HR Transdermal System [Nitrodisc] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360476 | nitroglycerin 0.3 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360476 | nitroglycerin 0.3 MG/HR Transdermal System [Nitrodisc] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360477 | estradiol 0.00188 MG/HR / levonorgestrel 0.000625 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360478 | fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler [Flovent] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360478 | fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler [Flovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360479 | aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler [Tudorza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360479 | aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler [Tudorza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360480 | ipratropium bromide 0.018 MG/ACTUAT Metered Dose Inhaler [Atrovent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360481 | ciclesonide 0.08 MG/ACTUAT Metered Dose Inhaler [Alvesco] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360482 | insulin, regular, human 100 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360484 | diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360485 | meperidine hydrochloride 25 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360486 | isoproterenol hydrochloride 0.2 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360488 | estradiol 0.025 MG/Day Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360488 | estradiol 0.025 MG/Day Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360488 | estradiol 0.025 MG/Day Transdermal System | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360488 | estradiol 0.025 MG/Day Transdermal System | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360489 | fentanyl 0.05 MG/HR Transdermal System [Duragesic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360489 | fentanyl 0.05 MG/HR Transdermal System [Duragesic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360489 | fentanyl 0.05 MG/HR Transdermal System [Duragesic] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360490 | nicotine 0.875 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360491 | EPINEPHrine 0.16 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360491 | EPINEPHrine 0.16 MG/ACTUAT Metered Dose Inhaler | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360493 | sumatriptan 4 MG Cartridge [Imitrex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360493 | sumatriptan 4 MG Cartridge [Imitrex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360493 | sumatriptan 4 MG Cartridge [Imitrex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360494 | cephapirin 20 MG/ML Prefilled Syringe [Today] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360495 | liraglutide 6 MG/ML Pen Injector [Victoza] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360495 | liraglutide 6 MG/ML Pen Injector [Victoza] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360496 | VCR Sulfate 1 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360496 | VCR Sulfate 1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360496 | VCR Sulfate 1 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360497 | leuprolide acetate 30 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360498 | leuprolide acetate 15 MG/ML Prefilled Syringe [Lupron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360499 | amiodarone hydrochloride 50 MG/ML Prefilled Syringe [Nexterone] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360500 | fluphenazine decanoate 25 MG/ML Prefilled Syringe [Prolixin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360500 | fluphenazine decanoate 25 MG/ML Prefilled Syringe [Prolixin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360501 | medroxyprogesterone acetate 160 MG/ML Prefilled Syringe [depo-subQ provera] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360501 | medroxyprogesterone acetate 160 MG/ML Prefilled Syringe [depo-subQ provera] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360502 | hepatitis B immune globulin 217 UNT/ML Prefilled Syringe [Hyperhep B] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360503 | peginesatide 6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360504 | buprenorphine 0.005 MG/HR Transdermal System [BuTrans] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360504 | buprenorphine 0.005 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360505 | estradiol 0.00208 MG/HR Transdermal System [Climara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360505 | estradiol 0.00208 MG/HR Transdermal System [Climara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360506 | testosterone 0.208 MG/HR Transdermal System [Testoderm] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360506 | testosterone 0.208 MG/HR Transdermal System [Testoderm] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360507 | testosterone 0.167 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360508 | nicotine 0.938 MG/HR Transdermal System [Nicotrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360508 | nicotine 0.938 MG/HR Transdermal System [Nicotrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360509 | budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360509 | budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360509 | budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Symbicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360510 | glucose 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360511 | apomorphine hydrochloride 10 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360512 | peginterferon alfa-2b 0.16 MG/ML Prefilled Syringe [Pegintron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360514 | abatacept 125 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360515 | estradiol 0.00417 MG/HR Transdermal System [Esclim] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360515 | estradiol 0.00417 MG/HR Transdermal System [Esclim] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360516 | buprenorphine 0.02 MG/HR Transdermal System [BuTrans] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360516 | buprenorphine 0.02 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360517 | rotigotine 0.167 MG/HR Transdermal System [Neupro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360517 | rotigotine 0.167 MG/HR Transdermal System [Neupro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360518 | rotigotine 0.0417 MG/HR Transdermal System | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360518 | rotigotine 0.0417 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360518 | rotigotine 0.0417 MG/HR Transdermal System | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360519 | nitroglycerin 0.6 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360519 | nitroglycerin 0.6 MG/HR Transdermal System [Nitro-Dur] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360519 | nitroglycerin 0.6 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360519 | nitroglycerin 0.6 MG/HR Transdermal System [Nitro-Dur] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360521 | estradiol 0.00208 MG/HR Vaginal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360522 | albuterol 0.1 MG/ACTUAT / ipratropium bromide 0.02 MG/ACTUAT Inhalation Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360525 | alprostadil 0.01 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360528 | pegaptanib 3.33 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360529 | peginesatide 4 MG/ML Prefilled Syringe [Omontys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360530 | phenylephrine hydrochloride 0.05 MG/ML Prefilled Syringe | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360530 | phenylephrine hydrochloride 0.05 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360530 | phenylephrine hydrochloride 0.05 MG/ML Prefilled Syringe | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360621 | Mycoplasma pneumoniae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1360622 | Eclipta prostrata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1360623 | Oriental arborvitae pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360623 | Oriental arborvitae pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1360624 | Sanguisorba officinalis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1360625 | Tripterygium wilfordii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1360626 | (all-Z)-4,7,10,13,16-docosapentaenoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1360627 | pine needle oil (pinus mugo) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1360628 | Rumex crispus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1360629 | Zanthoxylum bungeanum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1360630 | Artemisia vulgaris top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1360631 | Oil of mustard | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1360631 | Oil of mustard | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360631 | Oil of mustard | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360631 | Oil of mustard | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1360631 | Oil of mustard | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1360632 | rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1360632 | rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1360633 | Neupro Titration Kit for Parkinson's disease Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1360633 | Neupro Titration Kit for Parkinson's disease Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1360633 | Neupro Titration Kit for Parkinson's disease Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1360634 | amoxicillin 100 MG [Amoxi-tabs] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1360635 | Amoxi-tabs 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360635 | Amoxi-tabs 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360635 | Amoxi-tabs 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360636 | amoxicillin 50 MG [Amoxi-tabs] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1360637 | Amoxi-tabs 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360637 | Amoxi-tabs 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360637 | Amoxi-tabs 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360638 | 1 nighttime (dextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG per 30 mL Oral Solution) / 1 daytime (dextromethorphan hydrobromide 15 MG per 15 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1360638 | 1 nighttime (dextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG per 30 mL Oral Solution) / 1 daytime (dextromethorphan hydrobromide 15 MG per 15 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1360638 | 1 nighttime (dextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG per 30 mL Oral Solution) / 1 daytime (dextromethorphan hydrobromide 15 MG per 15 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1360648 | corn starch 0.8 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1360649 | cornstarch 80 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360649 | cornstarch 80 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360649 | cornstarch 80 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360650 | corn starch 0.8 MG/MG [Soothe & Cool Powder] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1360651 | SOOTHE & COOL 80 % Topical Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360651 | SOOTHE & COOL 80 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360651 | SOOTHE & COOL 80 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360651 | SOOTHE & COOL 80 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360652 | witch hazel Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1360653 | witch hazel 0.1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360653 | witch hazel 0.1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360653 | witch hazel 0.1 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360654 | Pepcid AC 20 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360654 | Pepcid AC 20 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360654 | Pepcid AC 20 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360654 | Pepcid AC 20 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360713 | Tucoprim | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1360714 | sulfadiazine 0.333 MG/MG / trimethoprim 0.067 MG/MG [Tucoprim] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1360714 | sulfadiazine 0.333 MG/MG / trimethoprim 0.067 MG/MG [Tucoprim] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360715 | sulfadiazine / trimethoprim Oral Powder [Tucoprim] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360715 | sulfadiazine / trimethoprim Oral Powder [Tucoprim] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360716 | Tucoprim Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1360717 | Tucoprim Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1360718 | TUCOPRIM 67 MG / 333 MG per GM Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360720 | thonzylamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1360721 | Thonzylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1360721 | Thonzylamine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1360721 | Thonzylamine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1360722 | thonzylamine hydrochloride 3.33 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1360723 | phenylephrine / thonzylamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1360724 | phenylephrine / thonzylamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1360725 | phenylephrine / thonzylamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1360726 | phenylephrine / thonzylamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1360727 | phenylephrine HCl 10 MG / thonzylamine HCl 50 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1360727 | phenylephrine HCl 10 MG / thonzylamine HCl 50 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1360727 | phenylephrine HCl 10 MG / thonzylamine HCl 50 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1360728 | Nasopen PE | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1360729 | phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML [Nasopen PE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1360730 | phenylephrine / thonzylamine Oral Solution [Nasopen PE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1360731 | Nasopen PE Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1360732 | Nasopen PE Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1360733 | NASOPEN PE 10 MG / 50 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1360733 | NASOPEN PE 10 MG / 50 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1360733 | NASOPEN PE 10 MG / 50 MG in 15 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1360734 | chlophedianol / phenylephrine / thonzylamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1360735 | chlophedianol / phenylephrine / thonzylamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1360736 | chlophedianol / phenylephrine / thonzylamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1360737 | chlophedianol / phenylephrine / thonzylamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1360738 | chlophedianol hydrochloride 1.67 MG/mL / phenylephrine hydrochloride 0.667 MG/mL / thonzylamine hydrochloride 3.33 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360738 | chlophedianol hydrochloride 1.67 MG/mL / phenylephrine hydrochloride 0.667 MG/mL / thonzylamine hydrochloride 3.33 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360738 | chlophedianol hydrochloride 1.67 MG/mL / phenylephrine hydrochloride 0.667 MG/mL / thonzylamine hydrochloride 3.33 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360739 | Vanacof APE | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1360740 | chlophedianol hydrochloride 1.67 MG/ML / phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML [Vanacof APE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1360741 | chlophedianol / phenylephrine / thonzylamine Oral Solution [Vanacof APE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360742 | Vanacof APE Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1360743 | Vanacof APE Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1360744 | chlophedianol hydrochloride 1.67 MG/ML / phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Vanacof APE] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1360744 | chlophedianol hydrochloride 1.67 MG/ML / phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Vanacof APE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360745 | salicyclic acid 3 % / zinc pyrithione 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360745 | salicyclic acid 3 % / zinc pyrithione 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360745 | salicyclic acid 3 % / zinc pyrithione 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360746 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1360746 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1360746 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1360948 | hydrocortisone acetate 10 MG/ML [U-Cort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1360949 | U-Cort 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1360949 | U-Cort 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1360949 | U-Cort 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1360949 | U-Cort 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1360950 | hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML [Analpram HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1360954 | Analpram HC Cream 1 % / 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1360954 | Analpram HC Cream 1 % / 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1360954 | Analpram HC Cream 1 % / 1 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1360955 | hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML [Analpram HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1360956 | Analpram HC 2.5 % / 1 % Rectal Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1360956 | Analpram HC 2.5 % / 1 % Rectal Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1360956 | Analpram HC 2.5 % / 1 % Rectal Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361 | Benactyzine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1361 | Benactyzine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1361 | Benactyzine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1361015 | papaverine hydrochloride 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361018 | phentolamine mesylate 0.235 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361019 | phentolamine mesylate 0.4 MG in 1.7 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361019 | phentolamine mesylate 0.4 MG in 1.7 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361019 | phentolamine mesylate 0.4 MG in 1.7 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361020 | phentolamine mesylate 0.235 MG/ML [OraVerse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1361021 | OraVerse 0.4 MG in 1.7 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361021 | OraVerse 0.4 MG in 1.7 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361021 | OraVerse 0.4 MG in 1.7 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361021 | OraVerse 0.4 MG in 1.7 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361023 | phentolamine mesylate 5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361023 | phentolamine mesylate 5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361026 | heparin sodium, porcine 10 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361029 | heparin sodium, porcine 10 UNT/ML Injectable Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1361029 | heparin sodium, porcine 10 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1361029 | heparin sodium, porcine 10 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361029 | heparin sodium, porcine 10 UNT/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1361033 | heparin sodium, porcine 10 UNT/ML [Hep-Pak] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1361035 | heparin sodium, porcine 10 UNT/ML Injectable Solution [Hep-Pak] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361035 | heparin sodium, porcine 10 UNT/ML Injectable Solution [Hep-Pak] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361045 | cat skin extract 20000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361046 | Felis catus skin extract 20,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361046 | Felis catus skin extract 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361046 | Felis catus skin extract 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361047 | heparin sodium, porcine 100 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361048 | heparin sodium, porcine 100 UNT/ML Injectable Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1361048 | heparin sodium, porcine 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1361048 | heparin sodium, porcine 100 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361048 | heparin sodium, porcine 100 UNT/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1361197 | heparin sodium, porcine 100 UNT/ML [Hep-Pak] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1361198 | heparin sodium, porcine 100 UNT/ML Injectable Solution [Hep-Pak] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361198 | heparin sodium, porcine 100 UNT/ML Injectable Solution [Hep-Pak] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361199 | corn starch 0.79 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361200 | kaolin 0.04 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361201 | cornstarch 79 % / kaolin 4 % / zinc oxide 15 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361201 | cornstarch 79 % / kaolin 4 % / zinc oxide 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361201 | cornstarch 79 % / kaolin 4 % / zinc oxide 15 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361201 | cornstarch 79 % / kaolin 4 % / zinc oxide 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361204 | lidocaine hydrochloride 0.007 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361205 | lidocaine HCl 0.7 % / menthol 0.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1361205 | lidocaine HCl 0.7 % / menthol 0.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361205 | lidocaine HCl 0.7 % / menthol 0.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361208 | iodine 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361209 | chloroxylenol / iodine / menthol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1361210 | chloroxylenol / iodine / menthol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1361211 | chloroxylenol / iodine / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1361212 | menthol 1.27 % / chloroxylenol 0.5 % / iodine 0.02 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361212 | menthol 1.27 % / chloroxylenol 0.5 % / iodine 0.02 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361212 | menthol 1.27 % / chloroxylenol 0.5 % / iodine 0.02 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1361213 | Absorbine Veterinary Liniment | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1361214 | chloroxylenol 5 MG/ML / iodine 0.2 MG/ML / menthol 12.7 MG/ML [Absorbine Veterinary Liniment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1361215 | chloroxylenol / iodine / menthol Topical Solution [Absorbine Veterinary Liniment] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361216 | Absorbine Veterinary Liniment Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1361217 | ABSORBINE VETERINARY LINIMENT 1.27 % / 0.5 % / 0.02 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361217 | ABSORBINE VETERINARY LINIMENT 1.27 % / 0.5 % / 0.02 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1361217 | ABSORBINE VETERINARY LINIMENT 1.27 % / 0.5 % / 0.02 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361225 | heparin sodium, porcine 1000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361226 | heparin sodium, porcine 1000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361226 | heparin sodium, porcine 1000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361397 | Backaid IPF | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1361398 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Backaid IPF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1361399 | acetaminophen / aspirin / caffeine Oral Tablet [Backaid IPF] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361400 | Backaid IPF Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1361401 | Backaid IPF Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1361402 | BACKAID IPF Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361402 | BACKAID IPF Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361402 | BACKAID IPF Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361402 | BACKAID IPF Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361406 | capsaicin 0.000325 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361407 | lidocaine 0.045 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361408 | methyl salicylate 0.275 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361409 | capsaicin / lidocaine / menthol / methyl salicylate Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1361410 | capsaicin 0.0325 % / lidocaine 4.5 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361410 | capsaicin 0.0325 % / lidocaine 4.5 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361410 | capsaicin 0.0325 % / lidocaine 4.5 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361461 | Atropa belladona whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1361462 | Sus scrofa large intestine preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1361463 | Tylophora indica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1361491 | Bidens tripartita flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1361492 | glimepiride 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361493 | glimepiride 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361493 | glimepiride 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361494 | glimepiride 8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361495 | glimepiride 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361495 | glimepiride 8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361510 | Nexafed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1361511 | pseudoephedrine hydrochloride 30 MG [Nexafed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1361512 | pseudoephedrine Oral Tablet [Nexafed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361513 | Nexafed Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1361514 | Nexafed Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1361515 | Nexafed 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361515 | Nexafed 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361515 | Nexafed 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361535 | propylhexedrine Nasal Inhalant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1361536 | propylhexedrine 250 MG Nasal Inhalant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361536 | propylhexedrine 250 MG Nasal Inhalant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361537 | propylhexedrine Nasal Inhalant [Benzedrex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361538 | Benzedrex 250 MG Nasal Inhalant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361538 | Benzedrex 250 MG Nasal Inhalant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361538 | Benzedrex 250 MG Nasal Inhalant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361561 | heparin sodium, porcine 2.5 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361562 | heparin sodium, porcine 2.5 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361563 | Follistim AQ 300 UNT in 0.36 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361563 | Follistim AQ 300 UNT in 0.36 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361563 | Follistim AQ 300 UNT in 0.36 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361563 | Follistim AQ 300 UNT in 0.36 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361567 | heparin sodium, porcine 2000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361568 | heparin sodium, porcine 10,000 UNT in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361568 | heparin sodium, porcine 10,000 UNT in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361568 | heparin sodium, porcine 10,000 UNT in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361569 | Follistim AQ 600 UNT in 0.72 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361569 | Follistim AQ 600 UNT in 0.72 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361569 | Follistim AQ 600 UNT in 0.72 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361569 | Follistim AQ 600 UNT in 0.72 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361572 | Follistim AQ 900 UNT in 1.08 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361572 | Follistim AQ 900 UNT in 1.08 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361572 | Follistim AQ 900 UNT in 1.08 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361572 | Follistim AQ 900 UNT in 1.08 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361573 | heparin sodium, porcine 20000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361574 | heparin sodium, porcine 20,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361574 | heparin sodium, porcine 20,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361574 | heparin sodium, porcine 20,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361576 | heparin sodium, porcine 2500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361577 | heparin sodium, porcine 25,000 UNT in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361577 | heparin sodium, porcine 25,000 UNT in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361577 | heparin sodium, porcine 25,000 UNT in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361593 | heparin sodium, porcine 25000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361594 | heparin sodium, porcine 25,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361594 | heparin sodium, porcine 25,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361606 | heparin sodium, porcine 40 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361607 | heparin sodium, porcine 20,000 UNT in 500 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361607 | heparin sodium, porcine 20,000 UNT in 500 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361607 | heparin sodium, porcine 20,000 UNT in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361608 | heparin sodium, porcine 40000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361609 | heparin sodium, porcine 40,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361609 | heparin sodium, porcine 40,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361612 | heparin sodium, porcine 50 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361614 | heparin sodium, porcine 5000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361615 | heparin sodium, porcine 5000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361615 | heparin sodium, porcine 5000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361654 | ethylenediamine tetraethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1361655 | guaraprolose (3500 MPA.S at 1 % ) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361655 | guaraprolose (3500 MPA.S at 1 % ) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1361656 | propylene glycol alginate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1361657 | 123-I | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361657 | 123-I | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1361657 | 123-I | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1361657 | 123-I | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1361657 | 123-I | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1361657 | 123-I | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1361658 | phenoxyethyl caprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1361659 | dimethicone/vinyl dimethicone crosspolymer (soft particle) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361659 | dimethicone/vinyl dimethicone crosspolymer (soft particle) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1361660 | Picrasma quassioides wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1361664 | typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361665 | hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1361666 | hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1361667 | hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1361668 | 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361669 | hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361678 | iodine 0.025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361679 | iodine 25 MG per 1 L Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361679 | iodine 25 MG per 1 L Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1361679 | iodine 25 MG per 1 L Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361688 | Neutraphorus Rex Skin Protectant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1361689 | dimethicone 10 MG/ML [Neutraphorus Rex Skin Protectant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1361690 | dimethicone Topical Cream [Neutraphorus Rex Skin Protectant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361691 | Neutraphorus Rex Skin Protectant Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1361692 | Neutraphorus Rex Skin Protectant 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361692 | Neutraphorus Rex Skin Protectant 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1361692 | Neutraphorus Rex Skin Protectant 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361692 | Neutraphorus Rex Skin Protectant 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361693 | Biclora-D | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1361694 | chlophedianol hydrochloride 25 MG / chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG [Biclora-D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1361695 | chlophedianol / chlorcyclizine / pseudoephedrine Oral Tablet [Biclora-D] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361696 | Biclora-D Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1361697 | Biclora-D Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1361698 | chlophedianol hydrochloride 25 MG / chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Biclora-D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361698 | chlophedianol hydrochloride 25 MG / chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Biclora-D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361701 | chlophedianol hydrochloride 25 MG / chlorcyclizine hydrochloride 25 MG [Biclora] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1361702 | chlophedianol / chlorcyclizine Oral Tablet [Biclora] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361703 | Biclora Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1361704 | biclora 25 MG / 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1361704 | biclora 25 MG / 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361704 | biclora 25 MG / 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1361705 | calcium carbonate 497 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361706 | calcium carbonate / sodium bicarbonate Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1361707 | calcium carbonate / sodium bicarbonate Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1361708 | calcium carbonate 497 MG / sodium bicarbonate 600 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361708 | calcium carbonate 497 MG / sodium bicarbonate 600 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1361708 | calcium carbonate 497 MG / sodium bicarbonate 600 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361757 | heparin sodium, bovine 5000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361760 | heparin sodium, bovine 5,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361760 | heparin sodium, bovine 5,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361768 | aluminum acetate 53 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1361769 | aluminum acetate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1361770 | aluminum acetate 5.3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1361770 | aluminum acetate 5.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361770 | aluminum acetate 5.3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1361799 | Flucelvax 2012-2013 Formula | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1361800 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Flucelvax 2012-2013 Formula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1361801 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Flucelvax 2012-2013 Formula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361802 | Flucelvax 2012-2013 Formula Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1361803 | 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2012-2013 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361803 | 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2012-2013 Formula] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1361804 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2012-2013 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1361852 | heparin sodium, porcine 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1361853 | heparin sodium, porcine 5000 UNT in 0.5 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1361853 | heparin sodium, porcine 5000 UNT in 0.5 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1361853 | heparin sodium, porcine 5000 UNT in 0.5 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 136198 | darifenacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 136198 | darifenacin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 136198 | darifenacin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 136198 | darifenacin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 136198 | darifenacin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362 | Diphenhydramine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1362 | Diphenhydramine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362 | Diphenhydramine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1362 | Diphenhydramine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362023 | heparin sodium, porcine 1 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362025 | heparin sodium, porcine 1 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362026 | heparin sodium, porcine 10 UNT per 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362026 | heparin sodium, porcine 10 UNT per 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362032 | undecylenate Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1362034 | FungiCure Maximum Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1362036 | undecylenate Topical Gel [FungiCure Maximum Strength] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362037 | FungiCure Maximum Strength Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1362039 | undecylenic acid 25 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362039 | undecylenic acid 25 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362039 | undecylenic acid 25 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362040 | undecylenic acid 0.25 MG/MG [FungiCure Maximum Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362041 | FungiCURE Maximum Strength 25 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362041 | FungiCURE Maximum Strength 25 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362041 | FungiCURE Maximum Strength 25 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362041 | FungiCURE Maximum Strength 25 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362042 | minocycline 100 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362042 | minocycline 100 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362042 | minocycline 100 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362043 | Soft Dine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1362044 | iodine 5 MG/ML [Soft Dine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362045 | iodine Topical Solution [Soft Dine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362046 | Soft Dine Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1362047 | SOFT DINE 0.5 % Iodine Teat Dip | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362047 | SOFT DINE 0.5 % Iodine Teat Dip | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362047 | SOFT DINE 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362047 | SOFT DINE 0.5 % Iodine Teat Dip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362049 | heparin sodium, porcine 10 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362050 | menthol 0.1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362050 | menthol 0.1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362050 | menthol 0.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362054 | heparin sodium, porcine 30 UNT in 3 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362054 | heparin sodium, porcine 30 UNT in 3 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362054 | heparin sodium, porcine 30 UNT in 3 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362058 | heparin sodium, porcine 100 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362059 | heparin sodium, porcine 1000 UNT in 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362059 | heparin sodium, porcine 1000 UNT in 10 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362059 | heparin sodium, porcine 1000 UNT in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362060 | heparin sodium, porcine 200 UNT in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362060 | heparin sodium, porcine 200 UNT in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362060 | heparin sodium, porcine 200 UNT in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362061 | heparin sodium, porcine 250 UNT in 2.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362061 | heparin sodium, porcine 250 UNT in 2.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362061 | heparin sodium, porcine 250 UNT in 2.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362062 | heparin sodium, porcine 300 UNT in 3 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362062 | heparin sodium, porcine 300 UNT in 3 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362062 | heparin sodium, porcine 300 UNT in 3 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362063 | heparin sodium, porcine 500 UNT per 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362063 | heparin sodium, porcine 500 UNT per 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362063 | heparin sodium, porcine 500 UNT per 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362064 | heparin sodium, porcine 2 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1362067 | heparin sodium, porcine 6000 UNT in 3 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362067 | heparin sodium, porcine 6000 UNT in 3 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362067 | heparin sodium, porcine 6000 UNT in 3 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362068 | heparin sodium, porcine 2000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362069 | heparin sodium, porcine 1000 UNT per 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362069 | heparin sodium, porcine 1000 UNT per 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362070 | heparin sodium, porcine 1000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362071 | hyaluronate Prefilled Syringe [Supartz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1362072 | Supartz 1 % in 2 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1362072 | Supartz 1 % in 2 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362072 | Supartz 1 % in 2 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362073 | sodium hyaluronate 10 MG/ML Prefilled Syringe [Supartz] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362073 | sodium hyaluronate 10 MG/ML Prefilled Syringe [Supartz] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362078 | undecylenic acid 250 MG/ML [FungiCure Maximum Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1362079 | undecylenate Topical Solution [FungiCure Maximum Strength] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1362080 | FungiCURE 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362080 | FungiCURE 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362080 | FungiCURE 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362080 | FungiCURE 25 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362082 | Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 136209 | Venofer | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1362131 | nepafenac 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1362132 | nepafenac 0.3 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362132 | nepafenac 0.3 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362132 | nepafenac 0.3 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362134 | arabica coffee oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362135 | Oil of basil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362135 | Oil of basil | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362135 | Oil of basil | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362136 | tetrahydrocurcumin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362136 | tetrahydrocurcumin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362137 | Oil of hyssop | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362137 | Oil of hyssop | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362137 | Oil of hyssop | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362138 | jojoba butter | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362139 | ziprasidone hydrochloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1362139 | ziprasidone hydrochloride anhydrous | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362139 | ziprasidone hydrochloride anhydrous | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362140 | ascorbyl tocopheryl maleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362141 | Picea mariana leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362142 | prolinamidoethyl imidazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362143 | sodium carbonate decahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1362144 | C12-15 pareth-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362145 | PEG-120 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362146 | linalool, ()- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362147 | hydroxyethyl cellulose (100 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362150 | zinc oxide 145 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362151 | zinc oxide 14.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362151 | zinc oxide 14.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362151 | zinc oxide 14.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362151 | zinc oxide 14.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362206 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362211 | Analpram 2.5 % / 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362211 | Analpram 2.5 % / 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362211 | Analpram 2.5 % / 1 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1362212 | hydrocortisone acetate 2.5 % / pramoxine 1 % Rectal Cream (30 x 4 GM) / pramoxine HCl 1 % Medicated Pad (18) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1362212 | hydrocortisone acetate 2.5 % / pramoxine 1 % Rectal Cream (30 x 4 GM) / pramoxine HCl 1 % Medicated Pad (18) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362213 | Analpram E 2.5 % / 1 % Rectal Cream (30 X 4 GM) / Prax 1 % Medicated Pad (18) Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1362213 | Analpram E 2.5 % / 1 % Rectal Cream (30 X 4 GM) / Prax 1 % Medicated Pad (18) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362213 | Analpram E 2.5 % / 1 % Rectal Cream (30 X 4 GM) / Prax 1 % Medicated Pad (18) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362214 | albuterol 2.5 MG / ipratropium bromide 0.5 MG per 2.5 ML Inhalation Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362220 | hydrocortisone 2.5 % / pramoxine HCl 1 % Rectal Cream (4 GM) / pramoxine HCl 1 % Medicated Wipe (1) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1362220 | hydrocortisone 2.5 % / pramoxine HCl 1 % Rectal Cream (4 GM) / pramoxine HCl 1 % Medicated Wipe (1) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362221 | Analpram E 2.5 % / 1 % Rectal Cream (4 GM) / Prax 1 % Wipe (1) Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1362221 | Analpram E 2.5 % / 1 % Rectal Cream (4 GM) / Prax 1 % Wipe (1) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362221 | Analpram E 2.5 % / 1 % Rectal Cream (4 GM) / Prax 1 % Wipe (1) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362222 | hydrocortisone acetate 2.5 % / pramoxine 1 % Rectal Cream (28.4 GM) / pramoxine 1 % Medicated Pad (6) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1362222 | hydrocortisone acetate 2.5 % / pramoxine 1 % Rectal Cream (28.4 GM) / pramoxine 1 % Medicated Pad (6) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362223 | Analpram E 2.5 % / 1 % Rectal Cream (28.4 GM) / Prax 1 % Medicated Pad (6) Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1362223 | Analpram E 2.5 % / 1 % Rectal Cream (28.4 GM) / Prax 1 % Medicated Pad (6) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362223 | Analpram E 2.5 % / 1 % Rectal Cream (28.4 GM) / Prax 1 % Medicated Pad (6) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362234 | dextromethorphan hydrobromide 40 MG / guaifenesin 400 MG / phenylephrine hydrochloride 10 MG per 10 ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362577 | 1,2,6-hexanetriol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362584 | 1,2-hexanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362615 | 2-octanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362616 | 7-dehydrocholesterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362617 | chloroxylenol 3.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362618 | chloroxylenol 0.375 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362618 | chloroxylenol 0.375 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362618 | chloroxylenol 0.375 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362685 | betadex | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362686 | diamond | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362688 | Shiitake mushroom extract | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362688 | Shiitake mushroom extract | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362688 | Shiitake mushroom extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362689 | protocatechualdehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362690 | rose bengal sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1362691 | 1-butene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362692 | Hydroxyethylmethylmethacrylate resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362692 | Hydroxyethylmethylmethacrylate resin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362692 | Hydroxyethylmethylmethacrylate resin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362692 | Hydroxyethylmethylmethacrylate resin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362692 | Hydroxyethylmethylmethacrylate resin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362692 | Hydroxyethylmethylmethacrylate resin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362693 | menthol 10 % / methyl salicylate 12 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362693 | menthol 10 % / methyl salicylate 12 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362693 | menthol 10 % / methyl salicylate 12 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362693 | menthol 10 % / methyl salicylate 12 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362694 | cadmium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362695 | Ammonium sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362695 | Ammonium sulfate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362695 | Ammonium sulfate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362695 | Ammonium sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362696 | butyric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1362697 | Carnosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362697 | Carnosine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362697 | Carnosine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362698 | Chloroform | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362698 | Chloroform | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362698 | Chloroform | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362698 | Chloroform | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362698 | Chloroform | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362699 | Indium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362699 | Indium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362699 | Indium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362699 | Indium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362699 | Indium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362701 | benzocaine / cetylpyridinium / menthol Mucosal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1362702 | benzocaine / cetylpyridinium / menthol Mucous Membrane Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1362703 | benzocaine / cetylpyridinium / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1362704 | benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362704 | benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362704 | benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362705 | mexiletine hydrochloride 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1362706 | mexiletine HCl 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362706 | mexiletine HCl 150 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362706 | mexiletine HCl 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362706 | mexiletine HCl 150 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362707 | mexiletine hydrochloride 150 MG [Mexitil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362708 | mexiletine hydrochloride 150 MG Oral Capsule [Mexitil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362708 | mexiletine hydrochloride 150 MG Oral Capsule [Mexitil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362711 | mexiletine hydrochloride 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1362712 | mexiletine HCl 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362712 | mexiletine HCl 200 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362712 | mexiletine HCl 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362712 | mexiletine HCl 200 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362713 | mexiletine hydrochloride 200 MG [Mexitil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362714 | mexiletine hydrochloride 200 MG Oral Capsule [Mexitil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362714 | mexiletine hydrochloride 200 MG Oral Capsule [Mexitil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362719 | mexiletine hydrochloride 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1362720 | mexiletine HCl 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362720 | mexiletine HCl 250 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362720 | mexiletine HCl 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362720 | mexiletine HCl 250 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362721 | mexiletine hydrochloride 250 MG [Mexitil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362722 | mexiletine hydrochloride 250 MG Oral Capsule [Mexitil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362722 | mexiletine hydrochloride 250 MG Oral Capsule [Mexitil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362723 | mexiletine hydrochloride 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362724 | Mexiletine hydrochloride 25 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362724 | Mexiletine hydrochloride 25 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362724 | Mexiletine hydrochloride 25 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362725 | mexiletine hydrochloride 360 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362726 | mexiletine HCl 360 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362726 | mexiletine HCl 360 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362726 | mexiletine HCl 360 MG Extended Release Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362726 | mexiletine HCl 360 MG Extended Release Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362727 | mexiletine hydrochloride 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362728 | mexiletine HCl 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362728 | mexiletine HCl 50 MG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362728 | mexiletine HCl 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362728 | mexiletine HCl 50 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362729 | mexiletine hydrochloride 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362730 | mexiletine HCl 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362730 | mexiletine HCl 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362731 | mexiletine hydrochloride 200 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362732 | mexiletine hydrochloride 250 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362735 | phlorhizin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362737 | fludeoxyglucose (18F) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362737 | fludeoxyglucose (18F) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362738 | Octhilinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362738 | Octhilinone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362738 | Octhilinone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362738 | Octhilinone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362738 | Octhilinone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362738 | Octhilinone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362739 | 2-tert-butylbenzene-1,4-diol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362739 | 2-tert-butylbenzene-1,4-diol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362739 | 2-tert-butylbenzene-1,4-diol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362739 | 2-tert-butylbenzene-1,4-diol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362739 | 2-tert-butylbenzene-1,4-diol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362739 | 2-tert-butylbenzene-1,4-diol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362740 | 1,4-phenylenediamine base | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362740 | 1,4-phenylenediamine base | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362740 | 1,4-phenylenediamine base | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362740 | 1,4-phenylenediamine base | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362740 | 1,4-phenylenediamine base | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362740 | 1,4-phenylenediamine base | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362740 | 1,4-phenylenediamine base | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362740 | 1,4-phenylenediamine base | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362741 | ceramide NP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362741 | ceramide NP | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362742 | cobalt sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362743 | dipyrithione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362744 | dodicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362746 | teprenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362746 | teprenone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362747 | calcium formate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1362748 | formate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362751 | melatonin Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1362752 | melatonin Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1362753 | melatonin 2.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362753 | melatonin 2.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362767 | brompheniramine maleate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362768 | Brompheniramine maleate 10 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362768 | Brompheniramine maleate 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362768 | Brompheniramine maleate 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362769 | brompheniramine maleate 10 MG/ML [Codimal A] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362770 | brompheniramine maleate 10 MG/ML Injectable Solution [Codimal A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362770 | brompheniramine maleate 10 MG/ML Injectable Solution [Codimal A] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362781 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362781 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362782 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML [Codimal DH] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362782 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML [Codimal DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362783 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution [Codimal DH] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362783 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution [Codimal DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362783 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution [Codimal DH] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362783 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML / pyrilamine maleate 1.67 MG/ML Oral Solution [Codimal DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362789 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362789 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362790 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML [Codimal DH Reformulated Oct 2007] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362790 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML [Codimal DH Reformulated Oct 2007] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362791 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Codimal DH Reformulated Oct 2007] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362791 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Codimal DH Reformulated Oct 2007] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362791 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Codimal DH Reformulated Oct 2007] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362791 | dexchlorpheniramine maleate 0.2 MG/ML / hydrocodone bitartrate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Codimal DH Reformulated Oct 2007] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1362794 | Vernakalant | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362794 | Vernakalant | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362797 | brompheniramine maleate 10 MG/ML [Nasahist B] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362798 | brompheniramine maleate 10 MG/ML Injectable Solution [Nasahist B] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362798 | brompheniramine maleate 10 MG/ML Injectable Solution [Nasahist B] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362800 | brompheniramine maleate 10 MG/ML [Histine-B] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362801 | brompheniramine maleate 10 MG/ML Injectable Solution [Histine-B] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362801 | brompheniramine maleate 10 MG/ML Injectable Solution [Histine-B] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362802 | vitamin K 0.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1362803 | calcium carbonate / cholecalciferol / vitamin K Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1362804 | calcium carbonate / cholecalciferol / vitamin K Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1362805 | calcium 500 MG / vitamin D3 1000 UNT / phytonadione 40 MCG Chewable Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362805 | calcium 500 MG / vitamin D3 1000 UNT / phytonadione 40 MCG Chewable Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362805 | calcium 500 MG / vitamin D3 1000 UNT / phytonadione 40 MCG Chewable Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362806 | betaine hydrochloride 162 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1362807 | papain 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1362808 | betaine / bromelains / pancreatin / papain / pepsin A Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1362809 | betaine / bromelains / pancreatin / papain / pepsin A Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1362810 | betaine / bromelains / pancreatin / papain / pepsin A Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1362811 | betaine / bromelains / pancreatin / papain / pepsin A | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1362812 | betaine HCl 162 MG / bromelains 125 MG / pancreatin 250 MG / papain 125 MG / pepsin A 65 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362812 | betaine HCl 162 MG / bromelains 125 MG / pancreatin 250 MG / papain 125 MG / pepsin A 65 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362813 | Acacia decurrens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362814 | magnesium nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362815 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362816 | chlorpheniramine maleate 12 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362821 | heparin sodium, porcine 7500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362822 | heparin sodium, porcine 7500 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362823 | heparin sodium, porcine 8 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362824 | heparin sodium, porcine 8 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362829 | heparin sodium, bovine 1000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362830 | heparin sodium, bovine 1000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362831 | heparin sodium, porcine 10,000 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1362831 | heparin sodium, porcine 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362831 | heparin sodium, porcine 10,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1362832 | heparin sodium, bovine 10000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362833 | heparin sodium, bovine 10,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362833 | heparin sodium, bovine 10,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362836 | heparin sodium, porcine 12500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362837 | heparin sodium, porcine 12,500 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362837 | heparin sodium, porcine 12,500 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362871 | N-acetylglucosamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362871 | N-acetylglucosamine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362872 | propanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362872 | propanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362873 | Di-n-butylphthalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362873 | Di-n-butylphthalate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362873 | Di-n-butylphthalate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362873 | Di-n-butylphthalate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362873 | Di-n-butylphthalate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362873 | Di-n-butylphthalate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362874 | diatomaceous earth | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362875 | dodecanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362876 | maleic anhydride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362877 | propane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362878 | styrene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362879 | sulfur dioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362880 | pentylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362880 | pentylene glycol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362881 | acetyltributyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362882 | alfadex | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362882 | alfadex | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362883 | Ammonium acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362883 | Ammonium acetate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362883 | Ammonium acetate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362883 | Ammonium acetate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362883 | Ammonium acetate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362884 | ammonium hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362885 | benzimidazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362885 | benzimidazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362885 | benzimidazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362885 | benzimidazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362885 | benzimidazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362886 | chlorozotocin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362887 | cholesteryl nonanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362888 | chrysin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362889 | Cinnamyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362889 | Cinnamyl alcohol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362889 | Cinnamyl alcohol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362889 | Cinnamyl alcohol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362889 | Cinnamyl alcohol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362890 | citral | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362890 | citral | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362890 | citral | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362891 | ethohexadiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362892 | ethylparaben | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362892 | ethylparaben | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362892 | ethylparaben | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362892 | ethylparaben | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362892 | ethylparaben | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362892 | ethylparaben | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362892 | ethylparaben | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362893 | Hydroxycitronellal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362893 | Hydroxycitronellal | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362893 | Hydroxycitronellal | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362893 | Hydroxycitronellal | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362893 | Hydroxycitronellal | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362894 | maltol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362895 | mangiferin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362896 | mica | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362897 | myristyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362898 | polyoxyethylene-24-cholesteryl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362899 | potassium metabisulfite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362900 | BHA - Butylated hydroxyanisole | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362900 | BHA - Butylated hydroxyanisole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362900 | BHA - Butylated hydroxyanisole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362900 | BHA - Butylated hydroxyanisole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362900 | BHA - Butylated hydroxyanisole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362900 | BHA - Butylated hydroxyanisole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362901 | calcium pyrophosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362902 | dimyristoylphosphatidylcholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362903 | 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362904 | glycylglycine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362905 | Raffinose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362905 | Raffinose | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362905 | Raffinose | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362906 | Sarcosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362906 | Sarcosine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362906 | Sarcosine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362907 | Benzyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362907 | Benzyl salicylate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362907 | Benzyl salicylate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362907 | Benzyl salicylate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362907 | Benzyl salicylate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362908 | butyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362909 | Carbomer-940 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362909 | Carbomer-940 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362909 | Carbomer-940 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362909 | Carbomer-940 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362909 | Carbomer-940 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362910 | creosol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362911 | diethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362912 | saccharin calcium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1362913 | isododecane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362914 | saccharin sodium anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1362917 | aluminum silicate | British preferred term (PTGB) | YES | |
| Concept ID (RxCUI): 1362917 | aluminum silicate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362917 | aluminum silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362917 | aluminum silicate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362920 | pentigide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362921 | Diethylphthalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362921 | Diethylphthalate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362921 | Diethylphthalate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362921 | Diethylphthalate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362921 | Diethylphthalate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362921 | Diethylphthalate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362922 | diisopropanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362925 | diisopropylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362926 | N,N-dimethylamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362926 | N,N-dimethylamphetamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1362926 | N,N-dimethylamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362926 | N,N-dimethylamphetamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362926 | N,N-dimethylamphetamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1362926 | N,N-dimethylamphetamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362927 | lauryl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362927 | lauryl sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362928 | isostearyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362929 | methyl isobutyl ketone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362930 | rhodamine B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1362931 | Rosin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362931 | Rosin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362931 | Rosin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1362931 | Rosin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1362931 | Rosin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362931 | Rosin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362932 | methyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362932 | methyl laurate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362933 | isohexadecane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1362933 | isohexadecane | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1362935 | heparin sodium, porcine 2 UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362935 | heparin sodium, porcine 2 UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362936 | tolnaftate Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1362937 | tolnaftate 1 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362937 | tolnaftate 1 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362937 | tolnaftate 1 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362938 | Molecular AF | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1362939 | tolnaftate 10 MG/ML [Molecular AF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1362940 | tolnaftate Topical Oil [Molecular AF] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362941 | Molecular AF Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1362942 | Molecular AF 1 % Antifungal Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1362942 | Molecular AF 1 % Antifungal Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362942 | Molecular AF 1 % Antifungal Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362942 | Molecular AF 1 % Antifungal Topical Oil | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1362943 | heparin sodium, porcine 15000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362944 | heparin sodium, porcine 15,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362944 | heparin sodium, porcine 15,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362945 | heparin sodium, porcine 250 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362946 | heparin sodium, porcine 250 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362947 | heparin sodium, porcine 3000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362948 | heparin sodium, porcine 3,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362948 | heparin sodium, porcine 3,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362949 | heparin sodium, porcine 4000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362950 | heparin sodium, porcine 4,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362950 | heparin sodium, porcine 4,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362951 | heparin sodium, porcine 6000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362952 | heparin sodium, porcine 6,000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362952 | heparin sodium, porcine 6,000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362953 | heparin sodium, porcine 66 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362954 | heparin sodium, porcine 66 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362957 | heparin sodium, porcine 8.3 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362958 | heparin sodium, porcine 8.3 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362961 | heparin sodium, porcine 0.25 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1362962 | heparin sodium, porcine 12.5 UNT per 50 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1362962 | heparin sodium, porcine 12.5 UNT per 50 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1362962 | heparin sodium, porcine 12.5 UNT per 50 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363 | BJP - Bence Jones protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363 | BJP - Bence Jones protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363 | BJP - Bence Jones protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363 | BJP - Bence Jones protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 136300 | capromab pendetide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 136300 | capromab pendetide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 136300 | capromab pendetide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363010 | brompheniramine maleate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363011 | pseudoephedrine HCl 120 MG / brompheniramine maleate 10 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363011 | pseudoephedrine HCl 120 MG / brompheniramine maleate 10 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363014 | brompheniramine maleate 10 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363025 | brompheniramine maleate 10 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363025 | brompheniramine maleate 10 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363025 | brompheniramine maleate 10 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363027 | brompheniramine maleate 10 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363030 | propanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363030 | propanediol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363034 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363034 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363037 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363037 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine HCl 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363040 | isobutane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363043 | ether | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363043 | ether | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363043 | ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363043 | ether | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363044 | diphenylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363045 | chromium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363046 | ferric nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363047 | ferrous oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363048 | isobutyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363049 | Maltitol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363049 | Maltitol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363049 | Maltitol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363050 | maltodextrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363051 | monophosphoryl lipid A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363052 | 1-decanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363052 | 1-decanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363053 | Polydextrose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363053 | Polydextrose | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363053 | Polydextrose | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363054 | salicyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363055 | sorbitan monolaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363056 | Sorbitan oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363056 | Sorbitan oleate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363056 | Sorbitan oleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363056 | Sorbitan oleate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363056 | Sorbitan oleate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363056 | Sorbitan oleate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363057 | sorbitan monostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363058 | Sorbitan sesquioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363058 | Sorbitan sesquioleate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363058 | Sorbitan sesquioleate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363058 | Sorbitan sesquioleate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363059 | stannic oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363060 | sucrose stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363060 | sucrose stearate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363061 | tert-butyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363062 | 3-mercapto-1,2-propanediol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363062 | 3-mercapto-1,2-propanediol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363062 | 3-mercapto-1,2-propanediol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363062 | 3-mercapto-1,2-propanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363062 | 3-mercapto-1,2-propanediol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363212 | 12 HR chlorpheniramine maleate 8 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363215 | chlorpheniramine maleate 8 MG / pseudoephedrine HCl 120 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363215 | chlorpheniramine maleate 8 MG / pseudoephedrine HCl 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363220 | 12 HR guaifenesin 400 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363220 | 12 HR guaifenesin 400 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1363223 | guaifenesin 400 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363223 | guaifenesin 400 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1363228 | Gentaved 100 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363239 | brompheniramine maleate 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363240 | brompheniramine maleate 5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363241 | chlorpheniramine maleate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363242 | Chlorphenamine maleate 10 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363242 | Chlorphenamine maleate 10 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363242 | Chlorphenamine maleate 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363242 | Chlorphenamine maleate 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363243 | chlorpheniramine maleate 10 MG/ML [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363244 | chlorpheniramine maleate 10 MG/ML Injectable Solution [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363244 | chlorpheniramine maleate 10 MG/ML Injectable Solution [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363245 | chlorpheniramine maleate 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363246 | chlorpheniramine maleate 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363256 | guaifenesin 600 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363256 | guaifenesin 600 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1363256 | guaifenesin 600 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363256 | guaifenesin 600 MG / pseudoephedrine HCl 45 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1363263 | guaifenesin 600 MG / pseudoephedrine hydrochloride 45 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363263 | guaifenesin 600 MG / pseudoephedrine hydrochloride 45 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1363265 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363265 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363265 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363265 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363267 | cabozantinib s-malate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1363267 | cabozantinib s-malate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363267 | cabozantinib s-malate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363268 | cabozantinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363268 | cabozantinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363268 | cabozantinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363268 | cabozantinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363268 | cabozantinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363269 | cabozantinib 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1363270 | cabozantinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1363270 | cabozantinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363270 | cabozantinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363271 | cabozantinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1363272 | cabozantinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1363273 | cabozantinib 20 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363273 | cabozantinib 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363273 | cabozantinib 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363273 | cabozantinib 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363273 | cabozantinib 20 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363274 | Cometriq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1363275 | cabozantinib 20 MG [Cometriq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1363276 | cabozantinib Oral Capsule [Cometriq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363277 | Cometriq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1363278 | Cometriq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1363279 | Cometriq 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363279 | Cometriq 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363279 | Cometriq 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363280 | cabozantinib 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1363281 | cabozantinib 80 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363281 | cabozantinib 80 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363281 | cabozantinib 80 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363281 | cabozantinib 80 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363281 | cabozantinib 80 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363283 | cabozantinib 80 MG [Cometriq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1363284 | Cometriq 80 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363284 | Cometriq 80 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363284 | Cometriq 80 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363288 | chlorpheniramine maleate 12 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363288 | chlorpheniramine maleate 12 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363288 | chlorpheniramine maleate 12 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363289 | chlorpheniramine maleate 12 MG [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1363290 | Chlor-Trimeton Allergy 12 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363290 | Chlor-Trimeton Allergy 12 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363290 | Chlor-Trimeton Allergy 12 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363290 | Chlor-Trimeton Allergy 12 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363291 | chlorpheniramine maleate 12 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363292 | chlorpheniramine maleate 12 MG Extended Release Oral Tablet [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363292 | chlorpheniramine maleate 12 MG Extended Release Oral Tablet [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363293 | chlorpheniramine maleate 8 MG 8HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363293 | chlorpheniramine maleate 8 MG 8HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363293 | chlorpheniramine maleate 8 MG 8HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363294 | chlorpheniramine maleate 8 MG [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363295 | 8 HR chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363295 | 8 HR chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363295 | 8 HR chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363296 | chlorpheniramine maleate 8 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363297 | chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363297 | chlorpheniramine maleate 8 MG Extended Release Oral Tablet [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363298 | pseudoephedrine sulfate 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363299 | pseudoephedrine sulfate 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363299 | pseudoephedrine sulfate 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363300 | Chlor-Trimeton Nasal Decongestant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363301 | pseudoephedrine sulfate 60 MG [Chlor-Trimeton Nasal Decongestant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363302 | pseudoephedrine Oral Tablet [Chlor-Trimeton Nasal Decongestant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363303 | Chlor-Trimeton Nasal Decongestant Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363304 | Chlor-Trimeton Nasal Decongestant Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363305 | pseudoephedrine sulfate 60 MG Oral Tablet [Chlor-Trimeton Nasal Decongestant] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363305 | pseudoephedrine sulfate 60 MG Oral Tablet [Chlor-Trimeton Nasal Decongestant] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363306 | chlorpheniramine maleate 2 MG in 5 mL Oral Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363307 | chlorpheniramine maleate 0.4 MG/ML [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363308 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Chlor-Trimeton] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363308 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Chlor-Trimeton] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363309 | chlorpheniramine maleate 4 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363310 | chlorpheniramine maleate 4 MG [Chlor-Trimeton] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1363311 | Chlor-Trimeton 4Hour Allergy 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363311 | Chlor-Trimeton 4Hour Allergy 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363311 | Chlor-Trimeton 4Hour Allergy 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363312 | cabozantinib 140 MG Daily Dose, 20 MG (84), 80 MG (28) Oral Capsule Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1363312 | cabozantinib 140 MG Daily Dose, 20 MG (84), 80 MG (28) Oral Capsule Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363312 | cabozantinib 140 MG Daily Dose, 20 MG (84), 80 MG (28) Oral Capsule Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363312 | cabozantinib 140 MG Daily Dose, 20 MG (84), 80 MG (28) Oral Capsule Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363314 | chlorpheniramine maleate 4 MG [Aller-Chlor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1363315 | Aller-Chlor 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363315 | Aller-Chlor 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363315 | Aller-Chlor 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363316 | chlorpheniramine maleate 0.4 MG/ML [Aller-Chlor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363317 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Aller-Chlor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363317 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Aller-Chlor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363317 | chlorpheniramine maleate 0.4 MG/ML Oral Solution [Aller-Chlor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363318 | chlorpheniramine maleate 4 MG [Diabetic Tussin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363319 | Diabetic Tussin Allergy Relief 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363319 | Diabetic Tussin Allergy Relief 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363319 | Diabetic Tussin Allergy Relief 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363320 | chlorpheniramine maleate 4 MG [Teldrin HBP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363321 | Teldrin HBP 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363321 | Teldrin HBP 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363321 | Teldrin HBP 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363322 | chlorpheniramine maleate 4 MG [Wal-finate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1363323 | Wal-Finate 4 Hour Allergy 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363323 | Wal-Finate 4 Hour Allergy 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363323 | Wal-Finate 4 Hour Allergy 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363352 | hydroxyethyl starch 130-0.4 | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363352 | hydroxyethyl starch 130-0.4 | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363352 | hydroxyethyl starch 130-0.4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363360 | ivermectin Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1363361 | ivermectin Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1363362 | ivermectin Oral Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1363363 | ivermectin 1.87 % Oral Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363363 | ivermectin 1.87 % Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363363 | ivermectin 1.87 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363364 | guaiFENesin 525 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363364 | guaiFENesin 525 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1363364 | guaiFENesin 525 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363371 | guaifenesin 525 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363371 | guaifenesin 525 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1363375 | aluminum magnesium silicate 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363376 | sodium bicarbonate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363377 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1363378 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1363379 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1363380 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1363381 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1363382 | almasilate 125 MG / calcium carbonate 200 MG / sodium bicarbonate 200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363382 | almasilate 125 MG / calcium carbonate 200 MG / sodium bicarbonate 200 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363382 | almasilate 125 MG / calcium carbonate 200 MG / sodium bicarbonate 200 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363382 | almasilate 125 MG / calcium carbonate 200 MG / sodium bicarbonate 200 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363383 | aluminum magnesium silicate 83.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363384 | calcium carbonate 133.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363385 | sodium bicarbonate 133.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363386 | aluminum magnesium silicate / calcium carbonate / sodium bicarbonate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1363387 | almasiliate 83.3 MG / calcium carbonate 133.3 MG / sodium bicarbonate 133.3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363387 | almasiliate 83.3 MG / calcium carbonate 133.3 MG / sodium bicarbonate 133.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363387 | almasiliate 83.3 MG / calcium carbonate 133.3 MG / sodium bicarbonate 133.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363387 | almasiliate 83.3 MG / calcium carbonate 133.3 MG / sodium bicarbonate 133.3 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363388 | hydroxyethyl starch 130-0.4 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1363389 | hydroxyethyl starch 130-0.4 Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1363390 | hydroxyethyl starch 130-0.4 Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1363391 | hydroxyethyl starch 130-0.4 6 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363391 | hydroxyethyl starch 130-0.4 6 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363391 | hydroxyethyl starch 130-0.4 6 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363392 | hydroxyethyl starch 130-0.4 60 MG/ML [Voluven] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1363394 | Voluven 6 % in 500 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363394 | Voluven 6 % in 500 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363394 | Voluven 6 % in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363408 | Cometriq 140 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363409 | cabozantinib 100 MG Daily Dose, 20 MG (28), 80 MG (28) Oral Capsule Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1363409 | cabozantinib 100 MG Daily Dose, 20 MG (28), 80 MG (28) Oral Capsule Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363409 | cabozantinib 100 MG Daily Dose, 20 MG (28), 80 MG (28) Oral Capsule Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363409 | cabozantinib 100 MG Daily Dose, 20 MG (28), 80 MG (28) Oral Capsule Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363410 | Cometriq 100 MG Daily Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363414 | Chlorate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363415 | chlorpheniramine maleate 4 MG [Chlorate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363416 | chlorpheniramine Oral Tablet [Chlorate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363417 | Chlorate Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363418 | Chlorate Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363419 | chlorpheniramine maleate 4 MG Oral Tablet [Chlorate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363419 | chlorpheniramine maleate 4 MG Oral Tablet [Chlorate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363422 | Gentaved 100 Irrigation Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363423 | GentaVed 100 100 MG/ML Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363423 | GentaVed 100 100 MG/ML Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363423 | GentaVed 100 100 MG/ML Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363423 | GentaVed 100 100 MG/ML Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363426 | boron nitride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363427 | sodium lauroyl lactylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1363429 | alpha-arbutin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363430 | Atropa belladonna whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363431 | caprylyl trisiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363432 | decarboxy carnosine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1363434 | isopropyl laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363435 | lauric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1363437 | lime peel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363438 | sodium starch glycolate type a corn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1363440 | Passiflora edulis seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363441 | polyethylene glycol 450 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363442 | methyl stearic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363443 | muskmelon extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363444 | phytosphingosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363445 | polyglyceryl-2 dipolyhydroxystearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363446 | soy sterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363468 | Rhodomyrtus tomentosa fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363469 | Vachellia farnesiana flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363470 | Wal-Sleep Z | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1363471 | diphenhydramine hydrochloride 25 MG [Wal-Sleep Z] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1363471 | diphenhydramine hydrochloride 25 MG [Wal-Sleep Z] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1363472 | diphenhydrAMINE Oral Capsule [Wal-Sleep Z] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363472 | diphenhydrAMINE Oral Capsule [Wal-Sleep Z] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1363473 | Wal-Sleep Z Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1363474 | Wal-Sleep Z Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1363475 | Wal-Sleep Z 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363475 | Wal-Sleep Z 25 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1363475 | Wal-Sleep Z 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363475 | Wal-Sleep Z 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363486 | Ivercare | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363487 | ivermectin 0.0187 MG/MG [Ivercare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363490 | IverCare 1.87 % Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363490 | IverCare 1.87 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363490 | IverCare 1.87 % Oral Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363492 | xylometazoline hydrochloride 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363493 | xylometazoline HCl 0.1 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363494 | Aqua Maris Decongestant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363495 | xylometazoline hydrochloride 1 MG/ML [Aqua Maris Decongestant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363496 | xylometazoline Nasal Spray [Aqua Maris Decongestant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363497 | Aqua Maris Decongestant Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363498 | Aqua Maris Decongestant Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363499 | AQUA MARIS Decongestant 0.1 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363499 | AQUA MARIS Decongestant 0.1 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363499 | AQUA MARIS Decongestant 0.1 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363500 | phenylpropanolamine hydrochloride 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363501 | brompheniramine maleate 12 MG / phenylephrine hydrochloride 15 MG / phenylpropanolamine hydrochloride 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363502 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363502 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363502 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363502 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363503 | brompheniramine maleate 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363503 | brompheniramine maleate 6 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363503 | brompheniramine maleate 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363503 | brompheniramine maleate 6 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363504 | dexbrompheniramine maleate 6 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363504 | dexbrompheniramine maleate 6 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363505 | acetaminophen 500 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363505 | acetaminophen 500 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363505 | acetaminophen 500 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363506 | APAP 500 MG / dexbrompheniramine maleate 2 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363506 | APAP 500 MG / dexbrompheniramine maleate 2 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363507 | acetaminophen 650 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363507 | acetaminophen 650 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363507 | acetaminophen 650 MG / dexbrompheniramine maleate 2 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363508 | brompheniramine maleate 2 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363508 | brompheniramine maleate 2 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363508 | brompheniramine maleate 2 MG / dextromethorphan HBr 15 MG / guaiFENesin 200 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1363509 | brompheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363510 | brompheniramine tannate 2 MG/mL / dextromethorphan tannate 6 MG/mL / phenylephrine tannate 5 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363510 | brompheniramine tannate 2 MG/mL / dextromethorphan tannate 6 MG/mL / phenylephrine tannate 5 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363510 | brompheniramine tannate 2 MG/mL / dextromethorphan tannate 6 MG/mL / phenylephrine tannate 5 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363511 | brompheniramine maleate 2 MG/ML / phenylephrine hydrochloride 5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363512 | brompheniramine tannate 10 MG per 2 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363512 | brompheniramine tannate 10 MG per 2 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363513 | dexbrompheniramine maleate 2 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363513 | dexbrompheniramine maleate 2 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363553 | PCxx Neutral Foam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1363554 | sodium fluoride 20 MG/ML [PCxx Neutral Foam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1363555 | sodium fluoride Oral Foam [PCxx Neutral Foam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363556 | PCxx Neutral Foam Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1363557 | PCxx Neutral Foam Oral Foam Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1363558 | PCxx Neutral Foam 2 % Oral Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363558 | PCxx Neutral Foam 2 % Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363558 | PCxx Neutral Foam 2 % Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363558 | PCxx Neutral Foam 2 % Oral Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1363559 | dimethicone 1.2 % Topical Lotion (227 GM) / dimethicone 1.3 % Topical Lotion (71 GM) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1363559 | dimethicone 1.2 % Topical Lotion (227 GM) / dimethicone 1.3 % Topical Lotion (71 GM) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363561 | slim amaranth pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363561 | slim amaranth pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363561 | slim amaranth pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363562 | Rumex acetosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363563 | white clover pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363563 | white clover pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363564 | alum, potassium anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1363565 | decyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363566 | laureth-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363567 | hypromellose 2910 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363568 | carbomer-974P | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363568 | carbomer-974P | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363568 | carbomer-974P | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363569 | Dimethicone 350 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363569 | Dimethicone 350 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363569 | Dimethicone 350 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363570 | PEG-30 dipolyhydroxystearate (5000 MW) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363570 | PEG-30 dipolyhydroxystearate (5000 MW) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363570 | PEG-30 dipolyhydroxystearate (5000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363571 | 1,2-octanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363572 | methyl gluceth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363573 | laureth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363574 | methyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363575 | hexyldecanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363576 | cocamidopropylamine oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363577 | laureth-12 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363578 | cyclomethicone 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363579 | dimethiconol (41 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363580 | dipalmitoyl hydroxyproline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363581 | sodium C14-16 olefin sulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1363583 | hypromellose 2910-5cP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363584 | low-substituted hydroxypropyl cellulose, unspecified | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363584 | low-substituted hydroxypropyl cellulose, unspecified | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363585 | hydroxypropyl methylcellulose 2208 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363586 | hydroxypropyl methylcellulose 2910 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363587 | hydroxypropyl methylcellulose phthalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363588 | hypromellose 2208 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363589 | hypromellose 2910 3cP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363590 | hypromellose 2910 50cP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363593 | cocamidopropyl hydroxysultaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363594 | diethanolamine bis(C8-C18 perfluoroalkylethyl)phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363595 | diethanolamine cetyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363596 | diethylhexyl 2,6-naphthalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363597 | diglycol stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363598 | dihydroxyethyl cocamine oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363599 | diisobutyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 13636 | o-nitro-p-phenylenediamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 13636 | o-nitro-p-phenylenediamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 13636 | o-nitro-p-phenylenediamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 13636 | o-nitro-p-phenylenediamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363600 | diisopropyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363601 | diisopropyl sebacate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363602 | diisostearyl malate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363603 | Dilsea carnosa extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363604 | hydroxyethyl cellulose (3000 CPS at 1%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363605 | hydroxyethyl urea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363606 | hydroxymethyl cellulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363607 | hydroxypropyl corn starch (5% substitution by weight) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363608 | hydroxypropyl betadex | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363608 | hydroxypropyl betadex | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363608 | hydroxypropyl betadex | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363609 | Hypnea musciformis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363610 | melon extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363611 | PEG-15 glyceryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363612 | PEG-20 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363613 | PEG-4 dilaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363614 | PEG-4 laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363615 | PEG-40 sorbitan diisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363616 | PEG-5 oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363617 | PEG-6 lauramide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363618 | PEG-60 almond glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363619 | peg-75 lanolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363620 | PEG-75 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363621 | PEG-8 dioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363622 | peg-8 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363623 | PEG-8 laurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363624 | pomelo extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363624 | pomelo extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363625 | quaternium-18 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363626 | quaternium-52 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363627 | Asparagopsis armata extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363628 | butyl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363629 | brompheniramine tannate 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363630 | phenylephrine tannate 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363631 | phenylephrine tannate 15 MG / brompheniramine tannate 6 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363631 | phenylephrine tannate 15 MG / brompheniramine tannate 6 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363643 | sorbitan trioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363644 | squalane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363645 | steviol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363646 | sucrose acetate isobutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363647 | sucrose monolaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363648 | brompheniramine maleate 6 MG / phenylephrine HCl 15 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363648 | brompheniramine maleate 6 MG / phenylephrine HCl 15 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363651 | chlorpheniramine maleate 2 MG / methscopolamine nitrate 1.25 MG / phenylephrine hydrochloride 15 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363696 | propylene carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363697 | sodium silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363697 | sodium silicate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363697 | sodium silicate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363698 | aluminum tristearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363699 | stearamidoethyl diethylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363700 | dibutyl sebacate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363701 | sorbitan monopalmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363702 | Chlorothymol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363702 | Chlorothymol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363702 | Chlorothymol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363703 | Wool fat | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1363703 | Wool fat | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363703 | Wool fat | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363703 | Wool fat | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363704 | magnesium carbonate hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363705 | lauric acid diethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363706 | Isoeugenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363706 | Isoeugenol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363706 | Isoeugenol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363706 | Isoeugenol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1363706 | Isoeugenol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1363708 | methylethyl ketone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363709 | N,N'-diphenyl-P-phenylenediamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363709 | N,N'-diphenyl-P-phenylenediamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363709 | N,N'-diphenyl-P-phenylenediamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363709 | N,N'-diphenyl-P-phenylenediamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363709 | N,N'-diphenyl-P-phenylenediamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363709 | N,N'-diphenyl-P-phenylenediamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363710 | N-isopropyl-N-phenyl-4-phenylenediamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363711 | Morpholinylmercaptobenzothiazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363711 | Morpholinylmercaptobenzothiazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363711 | Morpholinylmercaptobenzothiazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363711 | Morpholinylmercaptobenzothiazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363711 | Morpholinylmercaptobenzothiazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363712 | padimate A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363713 | TMTM - Tetramethylthiuram monosulfide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363713 | TMTM - Tetramethylthiuram monosulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363713 | TMTM - Tetramethylthiuram monosulfide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363713 | TMTM - Tetramethylthiuram monosulfide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363713 | TMTM - Tetramethylthiuram monosulfide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363713 | TMTM - Tetramethylthiuram monosulfide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363714 | neurotrophin 3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363716 | saffron stain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363717 | isomalt | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363718 | Bacitracin methylenedisalycylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363718 | Bacitracin methylenedisalycylic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363718 | Bacitracin methylenedisalycylic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363718 | Bacitracin methylenedisalycylic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363719 | Tylosin phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363719 | Tylosin phosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1363719 | Tylosin phosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1363720 | myristyl lactate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363721 | niacinamide ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363722 | lithium benzoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1363724 | dextromethorphan tannate 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363725 | pyrilamine tannate 16 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363726 | dextromethorphan tannate 15 MG / phenylephrine tannate 10 MG / pyrilamine tannate 16 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363726 | dextromethorphan tannate 15 MG / phenylephrine tannate 10 MG / pyrilamine tannate 16 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363729 | Eucalyptus globulus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363730 | Sambucus nigra whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363731 | dextromethorphan tannate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1363732 | pyrilamine tannate 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1363733 | dextromethorphan tannate 25 MG / phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363733 | dextromethorphan tannate 25 MG / phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363736 | dextromethorphan tannate 5 MG/mL / phenylephrine tannate 2.5 MG/mL / pyrilamine tannate 6 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363736 | dextromethorphan tannate 5 MG/mL / phenylephrine tannate 2.5 MG/mL / pyrilamine tannate 6 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363749 | phenylephrine tannate 10 MG / pyrilamine tannate 16 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363749 | phenylephrine tannate 10 MG / pyrilamine tannate 16 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363750 | phenylephrine tannate 10 MG / pyrilamine tannate 16 MG [Deconsal CT] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363751 | Deconsal CT 10 MG / 16 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363751 | Deconsal CT 10 MG / 16 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363751 | Deconsal CT 10 MG / 16 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363752 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363752 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363752 | chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363753 | sodium fluoride 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363754 | eucalyptol / menthol / sodium fluoride / thymol Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1363755 | eucalyptol / menthol / sodium fluoride / thymol Mouthwash Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1363756 | eucalyptol / menthol / sodium fluoride / thymol Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1363757 | eucalyptol / menthol / sodium fluoride / thymol Mouthwash | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1363758 | eucalyptol / menthol / sodium fluoride / thymol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1363759 | eucalyptol 0.092 % / menthol 0.042 % / sodium fluoride 0.025 % / thymol 0.064 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363759 | eucalyptol 0.092 % / menthol 0.042 % / sodium fluoride 0.025 % / thymol 0.064 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363759 | eucalyptol 0.092 % / menthol 0.042 % / sodium fluoride 0.025 % / thymol 0.064 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363760 | ceftiofur hydrochloride 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1363761 | ceftiofur Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1363762 | ceftiofur HCl 500 MG in 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363762 | ceftiofur HCl 500 MG in 10 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363762 | ceftiofur HCl 500 MG in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363763 | Spectramast | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363764 | ceftiofur hydrochloride 50 MG/ML [Spectramast] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363765 | ceftiofur Prefilled Syringe [Spectramast] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363766 | Spectramast Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363767 | Spectramast DC 500 MG in 10 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363767 | Spectramast DC 500 MG in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363767 | Spectramast DC 500 MG in 10 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363767 | Spectramast DC 500 MG in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363768 | ceftiofur hydrochloride 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363769 | ceftiofur hydrochloride 50 MG/ML Prefilled Syringe [Spectramast] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363769 | ceftiofur hydrochloride 50 MG/ML Prefilled Syringe [Spectramast] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363770 | phenylephrine tannate 2 MG/ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363771 | Ah-Chew D Suspension | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363772 | phenylephrine tannate 2 MG/ML [Ah-Chew D Suspension] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363773 | phenylephrine Extended Release Suspension [Ah-Chew D Suspension] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363774 | Ah-Chew D Suspension Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363775 | Ah-Chew D Suspension Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363776 | phenylephrine tannate 2 MG/ML Extended Release Suspension [Ah-Chew D Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363776 | phenylephrine tannate 2 MG/ML Extended Release Suspension [Ah-Chew D Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363776 | phenylephrine tannate 2 MG/ML Extended Release Suspension [Ah-Chew D Suspension] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363777 | phenylephrine HCl 10 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363777 | phenylephrine HCl 10 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363778 | phenylephrine hydrochloride 10 MG [Ah-Chew D] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363779 | phenylephrine hydrochloride 10 MG Chewable Tablet [Ah-Chew D] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363779 | phenylephrine hydrochloride 10 MG Chewable Tablet [Ah-Chew D] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363780 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1363780 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1363780 | chlorpheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1363781 | chlorpheniramine maleate 12 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363784 | phenylephrine hydrochloride 10 MG [Nasop] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363785 | Nasop12 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363785 | Nasop12 10 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363785 | Nasop12 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363785 | Nasop12 10 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363786 | phenylephrine HCl 10 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363786 | phenylephrine HCl 10 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363787 | Nasop 10 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363787 | Nasop 10 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363787 | Nasop 10 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363788 | phenylephrine tannate 2.5 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363789 | V-Tann Suspension | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363790 | phenylephrine tannate 2.5 MG/ML / pyrilamine tannate 6 MG/ML [V-Tann Suspension] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363791 | phenylephrine / pyrilamine Oral Suspension [V-Tann Suspension] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363792 | V-Tann Suspension Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363793 | V-Tann Suspension Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363794 | phenylephrine tannate 2.5 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension [V-Tann Suspension] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363794 | phenylephrine tannate 2.5 MG/ML / pyrilamine tannate 6 MG/ML Oral Suspension [V-Tann Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363795 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363795 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363796 | V-Tann Chewable | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363797 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG [V-Tann Chewable] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363798 | phenylephrine / pyrilamine Chewable Tablet [V-Tann Chewable] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363799 | V-Tann Chewable Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363800 | V-Tann Chewable Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363801 | V-Tann Chewable Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363802 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet [V-Tann Chewable] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363802 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet [V-Tann Chewable] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363816 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG [Viravan-T] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363817 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet [Viravan-T] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363817 | phenylephrine tannate 25 MG / pyrilamine tannate 30 MG Chewable Tablet [Viravan-T] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363818 | phenylephrine tannate 1.5 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363821 | Nasop Suspension | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363822 | phenylephrine tannate 1.5 MG/ML [Nasop Suspension] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363823 | phenylephrine Oral Suspension [Nasop Suspension] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363824 | Nasop Suspension Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363825 | Nasop Suspension Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363826 | phenylephrine tannate 1.5 MG/ML Oral Suspension [Nasop Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363826 | phenylephrine tannate 1.5 MG/ML Oral Suspension [Nasop Suspension] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363826 | phenylephrine tannate 1.5 MG/ML Oral Suspension [Nasop Suspension] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363827 | distearoylethyl hydroxyethylmonium methosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363828 | acetaminophen 80 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363828 | acetaminophen 80 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1363828 | acetaminophen 80 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363831 | Pistacia lentiscus seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363896 | Berri-Freez | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1363897 | menthol 0.045 MG/MG [Berri-Freez] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1363898 | menthol Topical Gel [Berri-Freez] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363899 | Berri-Freez Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1363900 | Berri-Freez 4.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363900 | Berri-Freez 4.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1363900 | Berri-Freez 4.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363900 | Berri-Freez 4.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1363900 | Berri-Freez 4.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1363915 | bis-ethoxydiglycol succinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363916 | carmoisine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363917 | Streptococcus pneumoniae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363918 | Streptococcus agalactiae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363919 | Streptococcus viridans group | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363920 | Streptococcus mutans | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363985 | Actinidia chinensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363986 | triethanolamine lauryl sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363987 | sodium myristoyl sarcosinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1363989 | sodium cocoyl sarcosinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1363991 | limonene, ()- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1363992 | disodium ricinoleic monoethanolamide sulfosuccinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1363994 | monosodium ethylenediaminetetraacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1363996 | isostearyl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1363997 | triethanolamine benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1364048 | Lysol Touch of Foam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1364049 | benzalkonium chloride 1 MG/ML [Lysol Touch of Foam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1364050 | benzalkonium Medicated Liquid Soap [Lysol Touch of Foam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1364051 | Lysol Touch of Foam Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1364052 | Lysol Touch of Foam 0.1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1364053 | dimethicone 23 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1364054 | dimethicone 2.3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1364054 | dimethicone 2.3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1364054 | dimethicone 2.3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1364055 | dimethicone 43.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1364056 | dimethicone 4.36 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1364056 | dimethicone 4.36 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1364056 | dimethicone 4.36 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1364057 | Loxicom | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1364058 | meloxicam 5 MG/ML [Loxicom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1364059 | meloxicam Injectable Solution [Loxicom] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1364060 | Loxicom Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1364061 | Loxicom 5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1364061 | Loxicom 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1364061 | Loxicom 5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1364062 | mineral oil 99.9 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |